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Abstract 
 
Vascular tissue engineering aims to design more reliable substitutes for diseased 
or otherwise failed blood vessels. For this approach to be successful, the engineered 
blood vessel must provide similar structure and integrity to that of the native vascular 
tissue. Despite extensive studies documented in scientific literature, the designing of 
clinically-relevant vascular tissue has been largely unsuccessful. One of the challenges is 
our lack of understanding on how vascular smooth muscle cells (VSMCs) and vascular 
endothelial cells (VECs) interact in the graft. The objective of this study was to examine 
the factors that play a role in VSMC and VEC interaction in 3D co-culture so that a 
compliant graft can be constructed. Highly porous 3D poly(carbonate urethane) (PCU) 
scaffolds were fabricated using a solvent casting particulate leaching method. Human 
coronary artery smooth muscle cells (HCASMCs) and human coronary artery endothelial 
cells (HCAECs) were seeded sequentially on scaffolds containing basal and medial 
adhesion protein layers. Co-cultures were carried out and stained to allow observation of 
cell orientation and morphology. Results showed that HCASMCs readily attached to the 
scaffold and formed dense confluent layers which facilitated the attachment and 
organization of HCAECs into a monolayer above the HCASMC layer. In addition, the 
HCAECs showed a greater affinity toward the HCASMCs than to the scaffold. Western 
blot analysis showed that co-culture induced an up-regulation of the contractile 
phenotype in HCASMCs as well as the Notch3 receptor and its ligand Jagged1. In order 
to identify the link between Jagged1 and the expression of contractile proteins a Jagged 1 
knockdown study was conducted using small interfering RNA (siRNA). Results showed 
a reduction in smooth muscle α-actin and calponin in co-cultures treated with Jagged1 
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siRNA compared with expression levels in co-cultures treated with control siRNA. It can 
therefore be concluded that the Jagged1-Notch3 pathway is an important regulator of 
VSMC phenotype and can be taken advantage of when fabricating engineered tissues.  
 
Keywords: tissue engineering, vascular smooth muscle cell, vascular endothelial cell, co-
culture, polyurethane scaffolds, phenotype modulation, contractile protein expression, 
Notch signaling, Jagged1 
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Chapter 1 - Introduction 
 
1.1 Overview 
 
One of the strongest motivators behind the field of vascular tissue engineering is 
the ever-present incidence of coronary artery disease (CAD). Cardiovascular diseases- of 
which CAD comprises the majority- are currently the number one cause of death 
worldwide1 and are projected to increase in prevalence with the aging of the baby boomer 
population and a growing incidence of diabetes2. Autologous vessels are the most reliable 
option for the replacement of diseased coronary arteries and as such are the most 
frequently used. Graft vessels are generally harvested from the internal mammary artery 
(IMA), saphenous vein (SV) or the internal thoracic artery3. The structure of the IMA 
matches well with that of the coronary artery and thus it provides a much more patent 
graft vessel as compared with the SV4. In addition to concerns with patency, the source 
for viable graft vessels may be depleted in many patients5-6. These individuals have the 
option of having a synthetic graft implanted; however, these grafts are accompanied by a 
high risk of bacterial infection, intimal hyperplasia and thrombus formation. Furthermore, 
their noncompliance with the native artery contributes to their limited use as coronary 
artery bypass grafts (CABGs)7. The emergence of vascular tissue engineering is triggered 
by the lack of major advancements in current therapies as a means to overcome the 
drawbacks that they present. In view of this, tissue engineering aims to produce 
functional living substitutes. The fundamental stages in the fabrication of a tissue 
engineered vascular substitute are: (1) expansion of cells and infiltration into a scaffold, 
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(2) maturation of the cell-scaffold construct to achieve the necessary mechanical and 
biological properties and (3) surgical implantation into the host8. Success with small-
diameter tissue engineered vascular grafts (TEVGs) has been limited and is attributed to a 
mismatch in compliance with the adjacent artery, misalignment of smooth muscle cells 
(SMCs) and insufficient amounts of elastin, collagen and SMCs9. These critical 
components can in principle be enhanced through strategic manipulation of SMC 
phenotype and it has been largely acknowledged that phenotype switching at the 
appropriate maturation stage would produce a TEVG that emulates the native tissue in 
structure, function and composition10-11. Investigators have sought to understand the role 
of various factors in the modulation of SMC phenotype including: matrix components, 
growth factors, scaffold geometry, mechanical stimulation and endothelial cell (EC)-
SMC interactions9. Much of the work completed thus far in the investigation of SMC in 
co-culture with EC has either relied on models that do not accurately represent the native 
in vivo conditions, has used exogenous stimuli that are inapplicable to tissue engineering 
applications or has assessed the production of matrix molecules in co-culture. However, a 
direct dependence of SMC phenotype on the presence of ECs has also been reported in 
literature12-13 and some of the mechanisms governing their interactions have started to 
emerge14-16. A deeper understanding of these mechanisms in the context of three-
dimensional (3D) engineered vasculature may enable their exploitation in the creation of 
more physiologically accurate substitutes. 
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1.2 Thesis Outline 
 
This thesis contains five chapters that detail the work carried out in the 
investigation of the interactions between vascular cells in 3D polyurethane scaffolds. 
Chapter 2 introduces the basis for vascular tissue engineering, illustrates the motivation 
for this study and outlines its specific objectives. The materials and experimental 
methodologies used are described in Chapter 3 and are followed by the significant 
findings of this work in Chapter 4. Chapter 5 summarizes the results and provides the 
significance and future directions of this project. 
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Chapter 2 - Literature Review 
 
2.1 Structure and Function of Blood Vessels  
 
Blood vessels are complex networks of hollow tubes with distinct structures that 
allow them to transport blood throughout the body. Oxygenated blood is pumped by the 
heart into the aorta which distributes the blood to large arteries. From here the blood is 
dispersed to smaller arteries, arterioles and finally capillaries where nutrient, oxygen and 
waste exchange occurs to and from tissues and organs. Venules then carry the oxygen-
depleted blood to larger veins and finally back to the heart1. Apart from small arterioles 
and capillaries, vessels are constructed of three distinct concentric layers that vary in 
thickness depending on the location of the vessel and its function1-2. The inner most layer 
that contacts the blood is the tunica intima and consists of a lining of ECs attached to a 
basement membrane of extracellular matrix (ECM) proteins1. Adjacent to the intima is 
the tunica media˗ a densely packed layer of SMCs. These SMCs are oriented 
circumferentially into dense layers with fenestrated elastic lamellae interspersed between 
them1,3. Veins do not function in a primarily contractile manner and so have a much 
thinner tunica media than do arteries.  The outermost layer is the tunica adventitia and is 
composed of fibroblasts and a collagenous ECM2 that protects and reinforces the blood 
vessel and anchors it to the surrounding tissue. Nerves and lymphatic vessels infiltrate the 
adventitia and provide further structural support3. In addition, arteries have an internal 
and external elastic lamina. The medial layer is bound by the elastic laminae where the 
majority of the elastin is concentrated4. The elastic tissue aids the vessel wall in 
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maintaining its resilience3 and imparts arterial elasticity under pulsatile flow5. The 
structure of an artery wall is shown in Figure 2.1.  
 
Figure 2.1: Structure of the artery wall2. (A) Organization of the intima, media and adventitia. 
(B) Cross-sectional view showing the organization of elastin in the media of muscular arteries 
(left) and elastic arteries (right).  
 
The endothelial monolayer was once thought to be a passive lining of the 
vasculature, but it is now known that it serves several important functions such as the 
prevention of thrombus formation, coagulation and intimal hyperplasia6. Under 
physiological conditions the glycocalyx layer on the ECs cells in conjunction with nitric 
oxide and prostacyclin prevent platelet adhesion7-8. Additionally, ectonucleotidases on 
the endothelial cell surface metabolize adenosine diphosphate which inhibits platelet 
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recruitment. Coagulation is initiated by the exposure of tissue factor to blood and 
progresses as fibrinogen is converted to fibrin by thrombin. Under normal conditions 
endothelial cells inhibit the tissue factor expression pathway and produce 
thrombomodulin which deactivates thrombin, thereby preventing the onset of 
coagulation6. Thrombus formation is also suppressed by the binding of antithrombin III 
to heparin sulfate proteoglycans. In the event that coagulation does occur, the endothelial 
cells release tissue type plasminogen activator to break up the fibrin clots7. Intimal 
hyperplasia is averted through the release of molecules that prevent SMC differentiation. 
The intact EC layer also controls the movement of molecules through the vascular wall, 
regulates vasomotor tone and maintains homeostatis of the vessel3.  
 
The function of the SMCs that populate the tunica media is to regulate the flow of 
blood. These cells are capable of shifting between a contractile phenotype, found in 
physiological conditions, and a synthetic phenotype which is characteristic of 
pathological conditions. In the contractile phenotype SMCs dilate and contract in a 
coordinated manner to increase or decrease the vessel diameter, thereby changing the 
flow of blood through the lumen2. Vasoactivity is modulated primarily by the SMCs and 
the neighboring ECs. The VSMCs receive neuronal or hormonal signals from the 
endothelial monolayer and react by generating the appropriate contractile force to meet 
the necessary blood pressure. Cells in the contractile phenotype have a spindle-shaped 
morphology, a centrally located nucleus and proliferate at a very low rate. This 
morphology can quickly transform to that of a fibroblast’s upon stimulation by 
pathological conditions. This state is known as the synthetic phenotype and is 
characterized by high levels of ECM production and proliferation7. 
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The mechanical properties of the blood vessel arise from a network of ECM 
component, namely: collagen (types I and III), fibrous elastin, proteoglycans (versican, 
decorin, biglycan, lumican, perlican), hyaluronan, and glycoproteins (laminin, 
fibronectin, thrombospondin, tenascin)1. Properties such as tensile stiffness, elasticity and 
incompressibility are imparted by collagens, elastin and proteoglycans respectively, while 
viscoelasticity is provided by the combination of all three1-2. The composition and 
organization of the ECM and the interactions between these proteins and the cells 
determine the degree of mechanical functioning in the blood vessel.  Additionally, these 
proteins provide anchorage to the cells, and guide the biological functions of the tissue 
under both physiological and pathological conditions.  This is achieved through bioactive 
domains on ECM molecules that can bind to structural or connecting proteins, signaling 
molecules (growth factors, cytokines, chemokines, and matrix proteinases) and 
membrane receptors.  Upon binding to cell surface receptors, intracellular signaling 
pathways can be activated or deactivated via either biochemical cues or 
mechanotransduction3.  
 
The internal and external elastic laminae have a convoluted structure that arises 
during vasculogenesis. A recent study9 of elastin fiber organization in rabbit aorta has 
shown that whereas the internal elastic laminae supports loading in the longitudinal 
direction – that is stretching along the vessel axis- , the external elastic laminae supports 
circumferential loading – that is stretching in the radial direction. At low strains, the 
elastin stretches for the duration of the pulse and returns to its original state as the pulse 
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wanes. These properties are critical since pressure waves arising from pulsatile blood 
flow act in both the radial and longitudinal directions4. The elastin molecules in the 
laminae also convey signals between the media and intima to regulate the phenotypic 
modulation, proliferation and organization of VSMCs and so are critical components of 
the arterial structure2.  
 
2.2 Coronary Arteries 
 
Coronary arteries have the same distinct structure as depicted in Figure 1; 
however, because they are considered to be muscular arteries, their medial layer 
constitutes the bulk of the arterial wall (left side of Figure 2.1B). Typically their internal 
diameter ranges from 3 to 4 mm with a wall thickness of 1 mm. Muscular arteries 
transport blood to organs at high pressures (80-120 mmHg) and experience shear stresses 
in the range of 0.75-2.25 Pa during a single cardiac cycle3. The pumping heart undergoes 
large deformations and so the coronary arteries are subjected to larger longitudinal strains 
and smaller circumferential wall strains (10-15%)10-11. The elastic laminae surrounding 
the tunica media allow the artery to recoil and prevent vascular dilation that would result 
from the creep of collagen under high blood pressures. For human coronary arteries, the 
burst pressure is about 2000 mm Hg (266 kPa)3. The coronary arteries originate at the 
root of the aorta and split into two branches that vascularize the myocardium. The left 
coronary artery supplies blood to the left atrium and left ventricle of the heart, while the 
right coronary artery supplies blood to the right atrium and right ventricle of the heart12. 
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2.3 Diseases of the Coronary Artery 
 
According to recent data, cardiovascular diseases – of which CAD comprises the 
majority- are the prevailing cause of death worldwide13. Incidences of CAD are expected 
to rise over the next 15 years due to increasing prevalence in developing countries and 
Eastern Europe as well as an increasing prevalence of obesity and diabetes14 which can 
lead to cardiovascular complications4. CAD most commonly arises from atherosclerosis, 
an inflammatory disease. It is initiated by injury (for example- high cholesterol or 
glucose, smoking and high blood pressure) to the endothelial lining of the blood vessel 
and eventually results in the formation of a complex lesion in the artery wall15. At 
physiological conditions, low density lipoprotein (LDL) in the blood infiltrates through 
the intima and is mostly eliminated on the abluminal side of the artery wall, though some 
of it is retained. In periods of hypercholestoremia, circulating levels of LDL are elevated.  
Accumulation of these molecules is facilitated by proteoglycans, of the ECM, which bind 
the LDL molecules. Subsequent oxidation of LDL particles results in the release of 
phospholipids that activate the endothelium16. ECs then upregulate expression of vascular 
cell adhesion molecule-1 (and various others) which recruit monocytes, lymphocytes, 
macrophages and mast cells (immune cells) causing them to adhere to these sites15. 
Chemokines produced in the intima stimulate their migration to the subendothelial 
space17-18. Monocytes then transform into macrophages which engulf the oxidized LDL 
particles and become foam cells17,19 while molecules such as platelet derived growth 
factor (PDGF), tumor necrosis factor (TNF) and interleukins change the qualitative 
composition of the ECM and induce phenotypic modulation of the VSMCs15. As foam 
cells rupture they release their lipid contents developing a lipid necrotic core which 
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continues to grow as SMCs migrate to the intima, proliferate and secrete ECM proteins 
that form a fibrous cap around the core15, 19-21. If unabated, this inflammatory response 
continues resulting in narrowing of the lumen which is compensated for by gradual 
dilation. However, it reaches a point where the lumen narrows so much that the flow of 
blood is altered to the succeeding tissues resulting in ischemia (inadequate blood supply 
to the heart). Furthermore, if the plaque becomes unstable and ruptures, coagulation is 
initiated resulting in a deep thrombus formation that can occlude the blood vessel leading 
to acute myocardial damage19,21.  
 
2.4 Surgical Interventions 
 
CABGs are the gold standard for treatment of diseased coronary arteries and as 
such are the most frequently used surgical intervention. Grafts of principally autologous 
tissue from the IMA, SV or internal thoracic artery are used. Although these vessels are 
considered of highest quality, they present several unresolved concerns.  SV grafts from 
elderly patients are prone to thrombus and neointima formation as well as atherosclerosis 
and aneurysms upon implantation at high pressure locations22. On average, patency rates 
after ten years tend to be high for IMA grafts but approximately 50% of SV grafts 
become occluded as a result of neo-intima formation23. The IMA is structurally more 
similar to the coronary artery than the SV (which tends to distend excessively resulting in 
failure23-24) and thus has a higher likelihood of remaining patent. In many patients (30-
50%), however, the supply of viable autologous vessels may not be sufficient due to their 
use in prior surgeries25-26. Additionally, the graft vessel may be diseased, rendering it 
unusable, or may not match the compliance of the target artery3, 4. Autologous vessels 
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commonly become thrombogenic causing SMCs to proliferate and migrate to the intima 
resulting in restenosis and eventual graft failure27. Recent studies have shown that SV 
graft failure may be reduced up to 70% with the insertion of stent28-29. Donor site 
morbidity is another serious complication of using vein grafts. Although the option of 
using allografts (same species but different donor) and xenografts (different species) 
exists, it is accompanied by a high risk of immune rejection and pathogen transmission15. 
Moreover, allografts have been associated with EC sloughing and reaction with 
leukocytes, poor patency, rejection and a loss of vascular reactivity; thus, they are no 
longer in use for by-pass surgery30. Patients who do not have available autologous tissue 
may receive a prosthetic graft. Synthetic materials such as expanded 
polytetrafluoroethylene (ePTFE) , and polyethylene teraphthalate (PET), also known as 
Dacron, have seen some success in large-diameter vessel replacement but have major 
flaws that limit their use in small-diameter, low flow vessels, like the coronary artery. 
These include compliance mismatch between the graft and native artery (due to a lack of 
viscoelasticity in the synthetic material), intimal hyperplasia especially around the 
anastomoses (location of suture), risk of bacterial infection (the graft may harbor 
bacteria) and thrombus formation on the internal surface of the graft30 (due to the lack of 
an endothelial lining)31. The continuous endothelial lining is an essential component of 
the graft as it provides a selectively permeable, anti-thrombotic barrier between the blood 
and artery wall by controlling platelet activation and adhesion32, and leukocyte 
adhesion33. Additionally, ECs regulate the vascular tone34 and SMC behaviour35. In larger 
artery replacements the endothelial lining is not as critical for long-term patency because 
the high blood flow rate does not allow platelets sufficient time to adhere to the graft. In 
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vessels such as the coronary artery however, the flow is markedly slower allowing 
immune cells to accumulate on the lumen of the graft15. Unfortunately, unlike what is 
observed in animal models, these grafts do not spontaneously endothelialize in humans36. 
In vitro seeding of ECs onto ePTFE grafts prior to use in coronary by-pass surgery has 
improved its long term patency to 91% at 2.5 years (for 4 mm diameter grafts) and 65% 
at 9 years (for 5 mm diameter grafts) compared with an average patency of 54% at 4 
years for non-endothelialized grafts. However, this approach requires a long culture 
period (2-4 weeks) prior to implantation27. Synthetic grafts also require extensive use of 
anticoagulant/ antithrombotic therapy to suppress immune rejection, which can have 
negative side effects15,30. 
 
Several non-invasive therapeutic options have emerged in recent years for the 
treatment of atherosclerosis. These include immunosuppressive drugs such as 
cyclosporine and sirolimus (also used for coating stents that are implanted for the 
treatment of post-angioplasty restenosis) which block T-cell activation, smooth muscle 
cell proliferation and inhibit intimal lesions. However, their efficacy in treating coronary 
syndromes is unknown. Results from the use of vaccination with oxidized LDL, bacteria 
containing modified phospholipids, or heat-shock protein 60 have been encouraging but 
additional elucidation is needed before they can be tested in humans17. 
 
Although significant progress has been made in the quality of therapies available 
there are still many challenges to overcome. Whilst life expectancy among afflicted 
individuals has improved and mortality rates have decreased as a result of advancements 
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in therapeutic treatments, the burden of disease still exists and may actually have 
increased. CAD can develop into a chronic condition if the implanted graft does not 
remain patent and repeated failures occur. In addition to the psychological impact of the 
disease they endure, many of these individuals live a debilitating lifestyle and have 
difficulty performing menial tasks. Thus the need for an alternative vascular replacement 
is urgent and indisputable37. Tissue engineering is one such alternative with great 
potential for providing a source of replacement vessels1. 
2.5 Vascular Tissue Engineering 
 
Over the last few decades tissue engineering has emerged to offer an alternative 
means of addressing the short comings of current therapies such as immune rejection and 
unavailability. Broadly defined, tissue engineering is “the application of principles and 
methods of engineering and life sciences toward fundamental understanding of structure-
function relationships in normal and pathological mammalian tissues and the 
development of biological substitutes to restore, maintain, or improve tissue function”38.  
The most widely used paradigm of tissue engineering (shown in Figure 2.2) 
involves the seeding of cells onto a scaffold (of natural or synthetic composition), 
maturation of cell-scaffold constructs in a metabolically and mechanically supportive 
environment (bioreactor) and the subsequent implantation of the engineered tissues to the 
appropriate anatomical location.  
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Figure 2.2: Tissue engineering paradigm showing the essential stages. Autologous cells are 
first harvested and expanded in vitro. This is followed by seeding of cells onto a natural or 
synthetic scaffold and maturation of the construct in a bioreactor. The engineered tissue is then 
implanted at the appropriate anatomical location.  
 
Once implanted, further remodeling allows tissue integration with the host 
tissue39. The various elements for successful tissue engineering are discussed below.  
 
2.5.1 Cell Source 
 
A variety of primary cell sources can be used for creating engineered tissues. 
Each has limitations and risks but can also offer unique advantages. Autologous cells are 
those that are harvested from the same patient into which the final tissue will be 
implanted. The advantage of using autologous cells is that they minimize the risk of 
inciting an adverse host immune response as well as the risk of disease transmission40. 
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The drawback is that these cells (especially from elderly patients) may be unavailable, 
have low proliferative capacity, require long expansion periods and have high 
variability39. Allogeneic cells are harvested from the same species but a different donor 
while xenogeneic cells come from a different species altogether. Both allogeneic and 
xenogeneic cells offer the advantage of creating engineered tissue banks that eliminate 
waiting times; however, their use is complicated by the risk of disease transmission and 
adverse host immune response40-41. Other potential sources of cells are adult stem cells, 
bone marrow stromal cells, bone marrow-dervied circulating stem cells and pluripotent 
embryonic stem cells39. 
 
2.5.2 Scaffolds 
 
Scaffolds are used to provide a 3D template to guide tissue generation and mimic 
the functions of native ECM. Because most primary cells are anchorage-dependant, they 
require a supporting material for survival and growth42. Scaffolds support cell adhesion, 
migration, proliferation, differentiation and contribute to the initial and/or final 
mechanical properties of the tissue. It has been shown that scaffold composition, 
degradation and architecture influence cell behaviour4,43. Scaffolds may be composed of 
natural or synthetic materials. Synthetic materials can be functionalized with bioactive 
ligands to deliver growth factors and signals or to direct 3D cell orientation. Upon 
implantation, if the scaffold is biostable, it also facilitates spatial arrangement of cells 
under aggressive in vivo conditions and contributes to the mechanical properties of the 
graft. Desirable characteristics of a scaffold are biocompatibility and biodegradability. 
Ideally, the scaffold should degrade at a rate that does not compromise the function of the 
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tissue while cells simultaneously go through the process of creating their own ECM to 
replace the scaffold44. However, commonly used biodegradable polymers (poly(L-lactic 
acid) (PLLA) and poly(glycolic acid) (PGA)) for vascular tissue engineering tend to 
generate acidic degradation products45-46 that  adversely affect VSMC behaviour47. 
 
2.5.3 The Role of Bioreactors 
 
Bioreactors play an important role in the maturation of engineered tissue. They 
supply the growing tissue with the necessary biochemical stimuli, such as oxygen and 
growth factors, and mechanical stimuli, such as tension, compression and shear, to mimic 
in vivo conditions. In the context of vascular tissue engineering this is a critical stage that 
promotes uniform cell distribution48, alignment, proliferation and secretion of ECM 
components.  Such stresses have been shown to improve the structural and mechanical 
properties of engineered tissues39. 
 
2.5.4 Implantation and Remodeling  
 
Remodeling by the host is often viewed as essential and beneficial stage of tissue 
engineering49.  Upon implantation, even autogolous constructs will induce immune 
reactions and undergo remodeling50.  This process can affect the functioning of the 
construct and may facilitate its successful integration into the surrounding tissue44. The 
degree to which a tissue engineered vascular grafts is remodeled is of critical importance.  
Excessive remodeling is undesirable as it can lead to intimal hyperplasia and restenosis 
after grafting4. 
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2.5.5 Applications of Tissue Engineering 
 
Tissue engineering allows for the fabrication of tailored blood vessels that 
respond to both mechanical and biological cues allowing them to easily acclimate to the 
native hemodynamic environment. They also have the ability to remodel, grow and 
repair, making them appealing for use in pediatric patients51-52. Apart from the obvious 
application of engineered tissues as replacement vessels, they can also serve as tools for 
studying normal physiological processes and pathogenesis of diseases. Furthermore, they 
can allow us to study the responses of tissue to injury, the toxicity of drugs on tissues and 
contractile responses in vascular tissues, enhance cell-based drug discovery and study 
interactions between cells and between cells and their surrounding matrix. Some 
examples of tissue engineered products that are currently in use or in development 
include: replacement skin, biohybrid extracorporeal artificial organs, cartilage 
regeneration using autolougous chondrocyte transplantation and a replacement thumb39. 
This shows the great potential of tissue engineering and the promise it holds as an 
alternative treatment modality. 
 
2.6 Missing Elements of Current TEVGs 
 
Despite the rapid progress that has been made in the field of vascular tissue 
engineering there are still several factors limiting graft function. Unlike other tissue 
engineering approaches, vascular grafts cannot rely on in vivo remodeling to approach 
functionality with time. They are designed to be implanted into demanding and dynamic 
environments and so must function immediately upon implantation. Some of the 
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requirements of engineered vascular grafts include: appropriate burst strength to 
withstand changes in blood pressure, matching compliance to the adjacent vessel, 
appropriate elasticity to withstand cyclic loading and a nonthrombogenic lining1. Many of 
these mechanical properties are imparted by the ECM proteins collagen and elastin. 
Indeed, a critical factor in the failure of current engineered conduits is a lack of these 
proteins. Furthermore, misalignment of SMCs in the longitudinal direction and low SMC 
numbers have also been identified as limiting factors of graft performance.  These 
problems can essentially be resolved with proper regulation of SMC phenotype4. For this 
reason, a key research area in the fabrication of small diameter blood vessels is the 
plasticity of smooth muscle cells30,53.  Both the synthetic and contractile phenotypes of 
VSMCs are needed for vascular tissue engineering in order to produce a graft that 
emulates the in vivo composition, morphology and function4.  The following section 
elaborates on vascular smooth muscle cell modulation with accompanying literature. 
 
2.7 VSMC Phenotype and Relevant Co-culture Studies 
 
2.7.1 VSMC Phenotype 
 
Despite the urgent need for a tissue engineered blood vessel, there are still several 
outstanding issues to resolve. Among these is the regulation of VSMC phenotype in 3D 
culture. VSMCs are known to exhibit remarkable plasticity in their native in vivo 
environment. One of the challenges in understanding the differentiation process that they 
undergo is that SMCs are present in a distinct synthetic and contractile phenotype as well 
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as a wide spectrum of phenotypes in between. These phenotypes are reversible and are a 
function of changing local environmental cues4,54-55. For example, during vasculogenesis 
SMCs are highly proliferative and migratory and lay down an abundance of ECM 
molecules such as collagen, elastin, proteoglycans, cadherins and integrins which 
constitute a majority of the blood vessel’s composition54. A critical step in vasculogenesis 
is the formation of gap junctions with ECs; these junctions play a major role in vessel 
maturation and remodeling56. Mature SMCs on the other hand acquire a contractile 
phenotype that is marked by a very low proliferative index, extremely low synthetic 
activity and expression of an array of contractile proteins, receptors, ion channels, 
calcium regulatory proteins and signaling molecules that are essential to the contractile 
activity of the cells57. Smooth muscle α-actin (SM-α-actin), smooth muscle myosin heavy 
chain (MHC), smoothelin-B, h-caldesmon and calponin are among the cytoskeletal 
proteins expressed by these cells58. The principle function of mature SMCs is the 
regulation of vessel tone-diameter, blood pressure and blood flow distribution54. The 
characteristic morphology of contractile VSMCs is spindle-like. This allows them to pack 
together into dense, circumferentially aligned layers that can translate individual 
contractions and dilations into macroscopic ones4. A unique characteristic of SMCs is 
that unlike skeletal or cardiac muscle cells, they are non-terminally differentiated, that is 
they have the ability to shift between phenotypes. Therefore, although these cells perform 
predominantly contractile functions they can easily revert to the synthetic phenotype if 
exposed to certain biochemical or biomechanical stimuli56,58. The transition to a synthetic 
phenotype involves suppression of genes that encode for contractile marker proteins and 
a pronounced increase in expression of genes that promote proliferation and matrix 
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turnover such as metalloproteinases and l-caldesmon54,59. The synthetic phenotype of 
mature SMCs is somewhat akin to the embryonic and fetal vascular smooth muscle 
phenotype60-61. Morphologically, cells in the synthetic phenotype resemble fibroblasts, 
have an extensive endoplasmic reticulum and few myofilaments. Furthermore, actin is 
present predominantly in the non-muscle p-form62. It is thought that the plasticity of 
SMCs has evolved as a survival mechanism and that mutations that hampered the ability 
of these cells to participate in vascular repair would have been detrimental and eventually 
diminished54-55. There are however, negative consequences to this, since SMCs will 
adversely switch phenotypes in the presence of abnormal environmental cues. De-
differentiation (shifting to synthetic phenotype) plays a key role in the development 
and/or progression of several diseases such as cancer, hypertension, and most notably 
atherosclerosis54. The phenotypic characteristics of VSMCs are illustrated in Figure 2.3 
below. 
 
Figure 2.3: Vascular smooth muscle morphology in physiological and pathological states4. 
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2.7.2 VSMC Phenotype Modulation in TEVGs 
 
The phenotype shifting property of VSMCs is considered of paramount 
importance in the construction of a functioning vasculature. Initially, the synthetic 
phenotype is desired to enable the cells to expand rapidly in culture. This would in turn 
promote infiltration and population of the scaffold by the VSMCs to create dense cell 
layers. This proliferation phase would also result in the secretion of appropriate ECM 
components to provide the tissue engineered vessel with sufficient mechanical properties 
and to provide a substrate for EC adhesion. Once the desired population of cells is 
achieved, the cells must then shift to a quiescent contractile phenotype to impart the 
vasoactive properties found in native blood vessels. Furthermore, the VSMCs must 
organize themselves circumferentially in order to constrict and dilate the construct in the 
necessary direction and to improve the mechanical properties4. Failure of the cells to 
differentiate would, upon implantation, result in the onset of intimal hyperplasia and 
restenosis, resulting in immediate graft failure58. It has been noted that significant causes 
of graft failure are misalignment of SMCs in the longitudinal direction, insufficient 
amounts of collagen, elastin and SMCs, all of which can be manipulated through the 
strategic regulation of VSMC phenotype4. Premature graft implantation causes SMCs to 
continually proliferate, thereby thickening the vessel wall and narrowing the lumen. 
VSMC phenotype switching from synthetic to contractile is considered crucial for the 
manufacture of a successful TEVG4. The tissue engineering strategies that are currently 
employed do not take advantage of this unique property to fabricate a blood vessel with a 
vascular media that mimics that of native arteries30,53. However, it is thought that 
manipulation of SMC phenotype at the appropriate maturation stage would be greatly 
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beneficial in creating a blood vessel substitute that more closely resembles native arteries 
in both organization and function63-64. For this reason, many investigators have studied 
the various factors that are involved in phenotype modulation of VSMCs. 
 
2.7.3 Factors Influencing VSMC Phenotype 
 
A variety of factors have been shown to influence the behavior of VSMCs 
including ECM components, growth factors, mechanical conditions and cell-cell 
interactions. It has also been observed that the initial phenotype of SMCs affects their 
subsequent response to the above mentioned stimuli65.  Furthermore, it has been observed 
that SMCs respond to some of these stimuli differently depending on whether they are 
grown in a two-dimensional (2D) environment versus a 3D environment.  
 
2.7.3.1 2D Substrates 
 
SMCs in healthy arteries exist in the contractile phenotype, but when harvested 
and grown on 2D culture dishes, they lose their contractility55,66. The loss of 
myofilaments occurs in parallel with the development of a large Glogi complex, rough 
endoplasmic reticulum and the secretion of ECM components. The expression of genes 
that promote α-actin production are downregulated while those that code for growth 
factors and their receptors are upregulated67. Collectively the introduction of SMCs into 
an in vitro culture environment results in a shift from a contractile to a synthetic 
phenotype over a period of days62. 
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2.7.3.1.1 ECM & Growth Factors 
As mentioned previously, SMCs in the native artery are embedded in a 3D matrix 
of fibrous ECM molecules. These proteins participate in the transduction of signals 
between the cell layers to regulate the adhesion, proliferation, migration and gene 
expression of the SMCs by way of transmembrane receptors known as integrins15,68. 
Thus, a host of in vitro studies have aimed to elucidate the specific effects of some of the 
major ECM proteins. Several of these studies have shown that the presence of fibronectin 
(FN) and type I collagen cause smooth muscle cells to shift to a synthetic phenotype4,69 
while other proteins such as laminin (LN), heparin, elastin and type IV collagen have the 
reverse effect, that is, they cause the cells to shift to a quiescent contractile phenotype4,70. 
It has also been shown that growth factors like basic fibroblast growth factor (bFGF), 
transforming growth factor-β1 (TGF- β1) and PDGF have regulatory effects on SMC 
phenotype; the effects of the latter two being the most profound. TGF-β1 seems to 
promote the migration of SMCs71-72 and increases ECM production73 but generally 
suppresses proliferation4. However, as mentioned previously, the initial phenotype of 
VSMCs can also dictate their response to certain stimuli. With respect to TFG-β1, rat 
aortic SMCs grown in its presence become less proliferative when the initial phenotype is 
a sub-confluent synthetic state. On the other hand, when confluent contractile cells are 
cultured with TGF-β1 they respond with a transition to the synthetic state, simulating 
hypertrophy61. Basic fibroblast growth factor bound to heparin sulfate proteoglycan has 
been found to upregulate SMC proliferation56; while PDGF has more of a chemotactic 
effect and indicates a shift to the synthetic phenotype by upregulating migration, 
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proliferation and ECM production74. LN, a basement membrane protein, has been shown 
to retard the transformation of SMCs to a synthetic phenotype and maintains the 
contractile phenotype for a long period of time upon initiation of in vitro culture 
(immediately after harvest)75. A study conducted by Li et al.62 tested the effects of 
Matrigel on smooth muscle cell phenotype. Matrigel is a solubilized basement membrane 
matrix whose primary component is LN62. In the study, rat aortic SMCs were cultured on 
plastic culture dishes (control) and on Matrigel coated culture dishes. The result was an 
induction of the contractile morphology in cells grown on Matrigel compared to the 
control group. Furthermore, cells grown on Matrigel had a low proliferative index, 
increased expression of SM-α-actin and MHC, and finally, they exhibited increased 
responsiveness to vasoconstrictors. Several studies have demonstrated a relationship 
between serum content in growth media and VSMC phenotype76-82. In the absence of 
serum or in very low serum concentrations it seems that SMCs shift from a synthetic to a 
contractile phenotype. Although this practice may be of use in in vitro cell culture 
studies, it cannot be adopted for tissue engineering procedures. Since the end goal is to 
introduce the tissue engineered product into the human body, the abundance of serum 
may undesirably trigger a pathological response (high synthetic activity). One of the 
challenges in studying the effects is that these various locally produced growth factors 
and matrix molecules tend to interact with each other to have a coordinated effect on the 
smooth muscle and their effects tend to be interdependent4,74,83. It should also be noted 
that these studies were conducted in a 2D environment and in serum-free conditions 
which do not accurately emulate the in vivo environment.  
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2.7.3.2 3D Substrates 
 
2.7.3.2.1 ECM & Growth Factors 
Several studies by Mequanint and co-workers have examined the effect of 
scaffold surface modification with matrix proteins on VSMC behavior. Matrigel-coated 
scaffolds, compared with bare scaffolds, promoted cell migration throughout the scaffold 
depth and resulted in cells that were aligned in parallel to each other with rich F-actin 
bundles, suggesting a differentiated phenotype84. A subsequent study comparing FN-
coated scaffolds with Matrigel-coated and bare scaffolds revealed that FN promoted cell 
infiltration to a greater extent than did Matrigel45. However, it was found that coating 
scaffolds with matrix molecules had no effect on contractile marker expression. Another 
study showed that polyurethane scaffolds conjugated with full length FN molecules 
displayed favourable interactions with human coronary artery smooth muscle cells 
(HCASMCs)85. Compared with the bare scaffold, the FN-functionalized scaffolds 
promoted cell infiltration. FN, as discussed earlier, induces the synthetic phenotype in 
SMCs. Therefore, fibronectin conjugated scaffolds have the potential to maintain SMCs 
in a de-differentiated phenotype in order to produce the necessary cell numbers and ECM 
components required of TEVGs. In a recent study, Baker and Southgate showed that LN 
pre-coating of electrospun polystyrene scaffolds promotes cell differentiation to a 
contractile phenotype86. As part of the same study, they found that the presence of serum 
proteins in the culture medium prevented differentiation of the cells on bare scaffolds. 
Upon removal of serum from the growth media, it was found that cells were no longer 
able to adhere to the scaffold. Therefore, in tissue engineering of blood vessels, which 
rely on the use of 3D scaffolds, serum withdrawal is not applicable.  
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2.7.3.2.2 Scaffold Geometry 
 Another known regulator of SMC phenotype is the geometry of scaffolds used in 
the engineering of vessels. Scaffolds aid in maintaining the spatial arrangement of cells, 
provide mechanical strength and can also provide biological cues to guide the 
development of the tissue. It has been shown that scaffold geometry can be used to 
regulate various processes in SMCs, including: proliferation, migration, attachment to the 
scaffold and other cells, differentiation and apoptosis43. Micropatterning is one such 
method used to design the scaffold architecture in such a way as to precisely control the 
behavior of cells. This is achieved through the addition of biological or chemical 
molecules and topographical features onto the scaffold surface. Micropatterned surfaces 
provide the advantage of replicating the dimensions and composition of the native in vivo 
environment. Studies have shown that patterning of substrates has resulted in the 
organization and alignment of SMCs into the contractile morphology4. For instance 
Goessl et al.87 used lithography while Ra et al.88 patterned a substrate with collagen to 
induce the spindle-like morphology. Problems associated with these studies include a 
restriction or inhibition of cell proliferation resulting from the narrow microchannels, and 
a large area of the substrate that is unavailable for cell growth. Furthermore, these studies 
focused on cell alignment but failed to show a phenotype shift from synthetic to 
contractile at the appropriate vessel maturation stage4.  
 
2.7.3.2.3 Mechanical Stimulation 
There are a variety of biomechanical stimuli in the native artery that make it an 
incredibly dynamic environment. For example, longitudinal blood flow through the 
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vessel exerts shear stress on the wall, while cyclic pressure variations due to blood flow 
exert radial and longitudinal forces. Furthermore, the cells of the vasculature respond to 
the constant stresses and strains and produce forces arising from vasoactivity. Of these, it 
has been shown that cyclic stretching has the strongest correlation to SMC phenotype 
generally resulting in increased ECM matrix secretion, cell proliferation, growth factor 
production and contractile activity4. In 2D culture, experiments have shown a relationship 
between cyclic strain and cell alignment. Mills et al.89 demonstrated the dependence of 
SMC alignment on the amount of cyclic strain. High strain (7-24%) was shown to align 
cells perpendicular to the strain gradient whereas low strains (0-7%) failed to organize 
the randomly aligned cells. Various other studies have demonstrated a mitogenic effect of 
mechanical strain and shear stress on SMC behavior through expression and activation of 
PDGF90-92. Wilson et al.93 found that cyclic strain (60 cycles/ min) induced SMC 
proliferation via production of PDGF. In the fabrication of vascular tissues, it has been 
demonstrated that the mechanical properties of the engineered vessel as well as cellular 
organization may be improved through dynamic mechanical conditioning. In a study by 
Niklason et al.94, pulsatile flow (5% radial distension at 165 pulses per minute) induced 
the desirable alignment of SMCs and production of large amounts of ECM proteins. 
Eight weeks of exposure resulted in high values for burst strength. Mooney and Mikos 
showed that cyclic strain improves histological organization and increased production of 
elastin and collagen, both of which contributed to an improvement in mechanical 
properties95. Seliktar et al.96 showed that engineered vessels consisting of rat aortic SMCs 
exposed to 10% cyclic strain at 1 Hz for 8 days resulted in even distribution of and 
circumferential orientation of cells as compared with static cultures. These responses are 
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further dependant on the particular substrate on which the cells are grown. For example, 
SMCs cultured (under cyclic mechanical strain) on FN or vitronectin were more 
proliferative and secreted ECM molecules in comparison to cells cultured on collagen or 
LN97. As promising as these results are, they also have drawbacks including long 
conditioning periods which makes them impractical for clinical use and the lack of 
formation of elastic laminae which contributes to irreversible creep in the graft vessel.  In 
addition, mechanical stimulation promotes the expression and activity of matrix 
metalloproteinase-2 (responsible for the degradation of short collagens) which would 
compromise the structure of the matrix. Furthermore, if mechanical conditioning is the 
only stimuli used to maintain the SMC organization up until implantation of the vessel, 
then risk of EC detachment poses another problem4. 
 
2.7.3.3 The Role of ECs to Regulate VSMC Phenotype 
 
ECs reside in close proximity to SMCs in the blood vessel and play an extensive 
role in coordinating SMC behavior through the production of growth factors, stimulators 
and inhibitors4. For instance, during blood vessel formation, ECs secrete PDGF and TGF 
– β1 to recruit VSMCs or pericytes to the newly formed endothelial tube. In mature 
arteries, the endothelium maintains homeostasis through the production of vasoactive 
agents such as eicosanoids. In particular, prostacyclin has been shown to maintain SMCs 
in a quiescent, contractile state in which they react to vasoactive stimuli but not to 
mitogens98. Heparin is another endothelium derived molecule that maintains the vascular 
media in a contractile phenotype while inhibiting proliferation and migration69. Much of 
what we currently know about the interactions between ECs and SMCs has been derived 
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from the study of vascular pathologies. In fact, atherosclerosis is initiated through a 
mechanical disruption in the endothelial monolayer15. The disrupted endothelium is no 
longer quiescent and becomes immunogenic. The subsequent cascade that is initiated 
results in the migration and proliferation of SMCs to the intima. Therefore, a quiescent 
endothelium is of critical importance in tissue engineered vascular grafts so as to not 
provoke a pathological SMC phenotype upon implantation into the body. Various groups 
have developed co-culture models to examine the interplay between these vascular cells. 
These include: conditioned media, co-culture on opposite sides of a porous membrane, 
microcarrier techniques, direct co-culture, and co-culture on a 3D collagen gel, which are 
summarized below.   
 
2.7.3.3.1 Conditioned Media 
It has been reported that medium conditioned by ECs in various stages of growth 
has an effect on smooth muscle phenotype, the results have however been mixed99-100. 
Unlike proliferating ECs, cells that are organized in a quiescent confluent layer produce 
heparin-like substances which have been shown to inhibit SMC proliferation99. A study 
conducted by Campbell and Campbell concluded that conditioned media from quiescent 
confluent endothelial cells shifted the SMCs into a contractile phenotype, whereas 
conditioned media from proliferating ECs did not suppress SMC proliferation99. On the 
other hand, Fillinger et al.100 found that conditioned media from quiescent confluent ECs 
actually increased SMC proliferation. Other investigators observed no significant changes 
in VSMC phenotype in culture with EC-conditioned media101-102. The results appear to be 
mixed and the response of the SMCs appears to be dependent on culture duration103-107.  
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2.7.3.3.2 Co-culture on Opposite Sides of a Membrane 
Fillinger et al.108 constructed a co-culture model by seeding ECs and SMCs on 
opposite sides of a 13µm thick PET membrane. They found that a confluent layer of ECs 
increased SMC proliferation initially but after 4 days seemed to inhibit cell growth. 
Additionally, the SMCs in co-culture displayed a spindle-like morphology. Van Buul-
Wortelboer et al.107 used collagen gel to separate the two cell layers in culture and found 
that in the presence of ECs, SMCs had lower proliferative activity. A study by Jacot and 
Wong showed that endothelium, once injured and allowed to partially re-endothelialize, 
induced a highly proliferative state in SMCs cultured on the opposite side of the same 
membrane compared with uninjured endothelium in co-culture109. The regulation of SMC 
behavior was attributed to PDGF-BB. Other studies110-111 altered serum concentration to 
induce the synthetic or contractile phenotype in SMCs and then tested its effect on EC or 
SMC gene expression or growth. Yet others112-113 used shear stress in a co-culture model 
on opposite sides of a membrane to elucidate its combined effect (with SMCs) on EC 
gene expression. In the native artery the internal elastic laminae, which separates the 
intimal layer (containing ECs) from the medial layer (containing SMCs), has a thickness 
ranging from 0.2 to 2 µm. Direct contact between the two cell layers is facilitated by 
fenestrations in the lamina of 1.5 µm depth. Therefore, using porous membranes in in 
vitro culture creates inaccurate models of native arterial structure. The large gap created 
by these membranes (10 microns or greater) may restrict diffusion of EC-produced 
molecules and gap junction formation between the ECs and SMCs114. Furthermore, the 
use of a synthetic membrane is not applicable in the engineering of blood vessels115.   
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2.7.3.3.3 Microcarrier Techniques 
Microcarrier techniques rely on use of small spheres/ spheroids as the adherent 
surface for anchorage-dependent cells. They are employed in order to achieve high yields 
of cells as they provide a much larger surface area for monolayer formation compared 
with standard culture dishes116. Korff et al.117 used a microcarrier system to construct co-
cultures of ECs and SMCs. They found that cells spontaneously organized into layers 
resembling that of an artery wall. However, as in many other co-culture systems, they 
only assessed the effect of SMCs on EC phenotype (proliferative vs. quiescent). Davies et 
al.118 used microcarrier techniques to study the influence of ECs on LDL metabolism by 
SMCs. These models, though important for investigating vascular cell interactions, are 
not viable from a tissue engineering perspective. A tissue-engineered blood vessel must 
have a tubular rather than spherical geometry in order to integrate into the surrounding 
tissue and mimic the native vessel functions. 
 
2.7.3.3.4 Direct Co-culture 
Niwa et al.119 compared the uptake of LDL and acetylated LDL by ECs in 
monoculture versus ECs in co-culture with SMCs.  Co-culture increased the uptake of 
LDL but had no effect on uptake of acetylated LDL.  Additionally, shear flow had a more 
pronounced effect on acetylated LDL uptake as compared with LDL uptake. In a study 
more relevant to this project, Hirschi et al.120 cultured ECs with multipotent embryonic 
10T1/2 cells (mural cell precursors). They demonstrated that co-culture induced a 
morphological shift from polygonal to spindle-like shape. Additionally, several 
contractile protein markers (MHC, smooth muscle 22α and calponin) were upregulated in 
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co-culture compared with monocultured 10T1/2 cells. The differentiation process was 
shown to be mediated by TGF-β. Similar results were observed in another study with ECs 
and 10T1/1 cells121. It has also been shown that EC attachment onto SMCs can be 
enhanced through the addition of ascorbic acid to increase collagen production by 
SMCs122. A co-culture study by Chaterji et al.123 demonstrated the influence of EC 
seeding density on SMC phenotype; culturing SMCs with near-confluent ECs 
upregulated the expression of SM-α-actin and calponin. Expression levels were further 
upregulated by pretreatment of SMCs with heparin and TGF-β. On the other hand, SMCs 
cultured with sparse amounts of ECs displayed a hyperplastic phenotype. Heydarkhan-
Hagvall et al.124 applied shear stress to a direct co-culture model to determine which 
genes were differentially expressed. The major finding was that co-culture is a significant 
factor in modulating EC responses to shear stress.  A series of studies conducted by 
Truskey and colleagues have used direct co-culture models to observe a variety of 
behaviors. However, in all of these studies they induced a quiescent SMC phenotype 
through serum withdrawal and examined primarily the behavior of ECs. These include: 
the adhesiveness of ECs on SMCs115,125 and molecules mediating adhesion126, the 
maintenance of a confluent endothelium under flow conditions, the effect of co-culture 
on EC response to TNF-α127 and the expression of tissue factor by ECs in co-culture128. It 
is important to note that all of these studies were performed on a 2D substrate. The major 
drawbacks of using 2D co-culture models are that they ignore hemodynamic forces by 
using static culture conditions or they ignore the effect of 3D geometry. A requirement of 
tissue-engineered vessels is that they must be in the form of a 3D cellular construct. Thus, 
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although data from 2D cultures can be used as a starting point, they may not truly reflect 
cell behavior on 3D substrates.  
 
2.7.3.3.5 Co-culture on 3D Collagen Gels 
An investigation by Ziegler et al.129 involved the construction of a co-culture 
system on 3D collagen gels. Porcine SMCs were embedded in a gel of collagen type 1 
over which ECs were seeded. The ECs exhibited an elongated shape and random 
orientation. Upon exposure to laminar shear stress the ECs aligned to the direction of 
flow. Additionally, the collagen matrix was significant in maintaining the ECs in a 
quiescent phenotype (as compared with plastic culture dishes that promoted 
proliferation). Similarly, Imberti et al.130 constructed a similar model of SMCs imbedded 
in a collagen matrix with an overlying layer of ECs. They also noticed that shear stress 
induced alignment of ECs in the direction of flow, as well as a quiescent endothelium that 
was attributed to the shear stress and collagen matrix. Neither of these studies, however, 
observed interactions between ECs and SMCs. 
Apart from the aforementioned studies, several investigators have carried out co-
cultures on 3D tubular scaffolds under dynamic growth conditions. Crouchley et al.131 
used a tubular silicone scaffold for the sequential seeding of SMCs and ECs. Application 
of mechanical stimulation resulted in the circumferential alignment of SMCs and was 
accompanied by an increase in contractile protein expression. Cells were also able to 
retain this phenotype after 24 hours of mechanical stimulation in co-culture. It should be 
noted that serum-withdrawal was used to induce contractility in SMCs. Williams and 
Wick sutured a biodegradable PGA nonwoven felt into a tubular construct that was 
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subsequently seeded with SMCs and ECs132. Long-term culture versus short-term culture 
in a bioreactor was compared. SMCs from long-term culture exhibited a more contractile 
phenotype and increased levels of proliferation compared with cells from short-term 
culture. ECM deposition had also decreased and was more uniform in long-term cultured 
constructs. Pullens et al.133 conducted a study in which myofibroblasts and ECs were 
cultured on 3D rectangular PGA and poly-4-hydroxybutyrate scaffolds for one or two 
weeks to assess the impact of culture medium composition and ECs on ECM deposition. 
Results indicated that EC culture medium and the presence of ECs in co-culture 
decreased collagen content in the scaffolds. 
In summary, these models have been important in elucidating the numerous 
interactions between ECs and SMCs but have notable drawbacks. 2D models fail to take 
into account the effect of geometry or hemodynamic forces observed in vivo. 
Furthermore, the use of membrane separated co-culture system cannot be applied to 
tissue engineering. Many of these studies also focused on the EC gene expression in co-
culture or the production of ECM proteins in 3D cultures. Recent reports have emerged 
that document an induction of the contractile phenotype in VSMCs by VECs120,134-136. 
The underlying mechanisms are only now beginning to emerge from 2D co-culture and 
gene knockout experiments137-139. Mechanisms that have been shown to play a role in this 
modulation are the PI3-kinase/Akt pathway140, the protein kinase A pathway via 
prostacyclin receptor141 and the Notch signaling pathway via Jagged1 ligand101,138,142-146.  
Due to the relevance of Notch signaling to this thesis, a brief review is presented. 
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The Notch signaling pathway is an evolutionarily conserved pathway that dictates 
cell fate through local cell-cell interactions. These interactions are critical in the control 
of cell proliferation, differentiation and apoptosis143. Components of the Notch signaling 
pathway include the Notch family of transmembrane receptors (Notch1 to 4), the Delta, 
Serrate/Jagged, Lag-2 family of transmembrane ligands (Delta like1, 3 and 4 and Jagged1 
and 2), and the various effectors from the hairy enhancer of split (HES) and HES-related 
repressor protein (HERP) family143, 144. The distribution of Notch signaling components 
within vertebrates varies significantly throughout tissues and during development. 
However, data suggests that several of these are confined to the vasculature including the 
ligands Delta like4, Jagged1 and 2, the receptors Notch1, 3 and 4 and the effectors 
HERP1, 2 and 3143. Interaction of the extracellular domain of the Notch receptors with 
their ligands on neighbouring cells leads to proteolytic cleavage of the receptor thereby 
freeing the Notch intracellular domain (ICD). Once the ICD translocates to the nucleus, it 
associates with C-promoter-binding factor-1 to form a multiprotein complex that initiates 
DNA transcription of the Notch effector genes (HES and HERP) 151. Notch signaling 
plays an important role in vascular development and in the pathogenesis of vascular 
diseases. In VSMCs in particular, Notch activity regulates cell differentiation, 
proliferation, migration and survival144, 152-153. Notch3 is the primary receptor that is 
expressed by VSMCs and its ligand Jagged1 is predominantly expressed by VECs143, 101, 
154-155. Impaired activity between Notch3 and Jagged1 has been shown to induce 
pathologies such as cerebral autosomal-dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL) and Alagille syndrome in humans143. Further data 
supporting the importance of Notch signaling in vasculature comes from experiments 
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involving the knockout of Jagged1 in mice which resulted in the absence of smooth 
muscle gene expression giving rise to an embryonic lethal phenotype156-157. Based on this 
evidence, the role of VEC-induced VSMC phenotype modulation via the Notch signaling 
pathway will be a focus of this study. 
 
2.8 Study Rationale and Objectives 
 
The shortcomings of CAD interventions have actuated a venture into the 
emerging field of vascular tissue engineering. More specifically, investigations 
undertaken by our laboratory have focused on the development of novel materials for use 
as vascular scaffolds and more recently on the interactions between VSMCs and 3D 
substrates. The failure of small-diameter vascular substitutes consisting of only a subset 
of the arterial components has spurred investigations of issues like VSMC phenotype 
regulation. It has been widely acknowledged that strategic control of VSMC phenotype at 
the appropriate tissue maturation stage would be greatly beneficial in creating a 
physiologically compliant vascular graft. Studies have shown that VECs play a key role 
in the modulation of VSMC phenotype. Investigation of VEC-induced VSMC phenotype 
modulation is therefore beneficial for the fabrication of TEVGs. In view of this, the 
purpose of this study was to characterize the interactions between HCASMCs and human 
coronary artery endothelial cells (HCAECs) on a 3D scaffold.  
 
In particular, we have chosen to study primary human coronary artery vascular 
smooth muscle and endothelial cells. Given that there are major functional differences 
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between vascular cells from different vascular beds147-148 and from different species149, 
the use of adult human coronary artery vascular cells best emulates the expected behavior 
of autologous cells150.  
 
We hypothesize that HCAECs will modulate the phenotype of HCASMCs from a 
synthetic to a contractile phenotype via the Notch signaling pathway when cultured on a 
3D substrate of PCU. To test this, we have set out the following specific objectives.  
 
i) Co-culture HCASMCs and HCAECs on porous 3D PCU scaffolds in distinct 
layers mimicking the native artery wall. 
ii) Determine if the presence of HCAECs has an effect on HCASMC phenotype 
through the examination of differentiation markers. 
iii) Elucidate whether any observed modulation of phenotype is mediated by Notch 3-
Jagged1 interactions. 
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Chapter 3 - Materials and Methods 
 
3.1 Materials 
 
A poly(carbonate urethane) (PCU; Bionate® 55D) was used to fabricate the 3D 
scaffolds in this study and was supplied by Polymer Technology Group (Berkeley, CA). 
Ammonium chloride (NH4Cl) supplied by Caledon Laboratories Ltd (Georgetown, ON, 
Canada) was used to create the porous structure of the scaffolds. Dimethylformamide 
(DMF) from Caledon Laboratories was used as a solvent for PCU. FN and Matrigel were 
supplied by Santa Cruz Biotechnology (Santa Cruz, CA) and Becton Dickenson (Franklin 
Lakes, NJ) respectively. Hank’s balanced salt solution (HBSS), used for solubilizing FN 
was supplied by Invitrogen (Burlington, ON, Canada). Penicillin G and streptomycin 
sulfate were purchased from Invitrogen. Cell culture studies were conducted utilizing 
primary HCASMCs and primary HCAECs in smooth muscle growth media (SmGM®-2 
BulletKit) (SmGM) and endothelial cell growth media (EGM®-2 Bullet Kit) (EGM), 
respectively, all of which was supplied by Lonza Walkersville Inc. (Walkersville, MD).  
For cell fixation purposes paraformaldehyde was purchased from EMD Chemicals 
(Gibbstown, NJ). Saponin, purchased from Sigma Chemical Co. (Germany), was used for 
cell permeabilization in some experiments. For immunostaining: Alexa Fluor® 488 
Phalloidin and CellTracker™ Green CMFDA (5-chloromethylfluorescein diacetate) 
(CTG) were purchased from Invitrogen (Eugene, OR), anti-VE-cadherin antibody was 
purchased from Santa Cruz Biotechnology and lastly Hoechst 33342 was purchased from 
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Sigma-Aldrich (Oakville, ON, Canada). Bovine serum albumin (BSA) was supplied by 
Sigma-Aldrich and Vectashield mounting medium was supplied by Vector Laboratories 
(Burlington, ON, Canada). Anti-PECAM-conjugated Dynabeads (Invitrogen Dynal AS, 
Oslo, Norway) were employed for cell separation in co-culture. Control and Jagged1 
siRNA ON-TARGETplus SMARTpool duplexes from Dharmacon were used for gene 
knockdown studies. siRNA reagents Opti-MEM reduced serum medium and 
Lipofectamine
™ 
RNAiMAX  Reagent  were purchased from Invitrogen (Grand Island, 
NY) and Invitrogen (Carlsbad, CA) respectively. Antibodies for use in Western blot 
(anti-SM α-actin, anti-calponin, anti-Notch 3, anti-Jagged1) were purchased from Santa 
Cruz Biotechnology with the exception of GAPDH which was purchased from Millipore 
(Temecula, CA). Protein concentrations were measured using 660 nm Protein Assay 
supplied by Thermo Scientific (Ottawa, Canada). SuperSignal® West Pico 
Chemiluminescent Substrate was supplied by Thermo Scientific (Rockford, IL). Protein 
G Dynabeads and recombinant human Jagged1/Fc chimera protein (1277-JG) were 
supplied by Invitrogen (Burlington, ON, Canada) and R&D Systems (Minneapolis, MN) 
respectively. RNA analysis of HCASMCs was achieved using TRIzol® Reagent and 
SuperScript™ from Invitrogen and a Chromo4 Real-time Thermal Cycler, iQ™ SYBR® 
Green Supermix and Gene Expression Macro analysis software from Bio-Rad 
(Mississauga, ON, Canada).  
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3.2 Methods 
 
3.2.1 Scaffold Fabrication 
 
PCU scaffolds were fabricated using a solvent casting and particulate leaching 
(SCPL) method as established in our laboratory1. In brief, NH4Cl porogen particles were 
ground to the diameter range of 180-210 µm using a mortar and pestle. Particles were 
then passed through graded sieves and those falling into the desired range of 180-212µm 
were collected. The collected particles were re-sieved to ensure they fell into narrow size 
distributions. Using the set-up shown below (Figure 3.1) the porogen was poured into the 
glass mold and compressed using air pressure to achieve high pore density and 
uniformity. A polymer solution consisting of 20% (w/v) PCU in DMF was added to the 
steel chamber and infiltration through the porogen bed was aided by the application of a 
pressure differential. The scaffold was then left for a period of three days to evaporate the 
solvent. The NH4Cl particles were then leached out using water (a non-solvent for PCU) 
after which the scaffold was dried (Figure 3.1B) and sectioned into 0.5mm thick discs 
(Figure 3.1C) prior to use in cell culture studies. 
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Figure 3. 1: Scaffold fabrication apparatus. Apparatus used for fabricating PCU scaffolds 
using SCLP technique (A); Resulting scaffold after porogen leaching and drying (B); Scaffold 
discs used for cell culture (C).                                                                                                                             
 
3.2.2 Scaffold Characterization 
 
To verify uniform scaffold structure and pore size, the fabricated scaffolds were 
imaged using a scanning electron microscope (SEM) (S-2600N, Hitachi, Japan). 
Scaffolds were sectioned into cylindrical disks of 5.5 mm diameter and 0.5 mm thickness 
using a rotary blade cutter, then sputter coated with gold and imaged. 
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3.2.3 Scaffold Preparation for Cell Culture 
 
Cylindrical scaffold disks were affixed to the bottom of a 96-well culture plate 
using silicone grease. A solution of FN diluted in HBSS was adsorbed onto the scaffold 
surfaces overnight in the dark at a density of 5µg/scaffold. Scaffolds were kept hydrated 
in HBSS prior to cell seeding.  
 
3.2.4 Cell Culture 
 
Primary HCASMCs and primary HCAECs were cultured in SmGM and EGM 
respectively. Both media were supplemented with 100 units/ml penicillin G and 100 
µg/ml streptomycin sulfate. Cell cultures were maintained in a humidified incubator at 
5% CO2 and 37°C and were used between passages 5 and 9. 
 
3.2.5 2D Monoculture 
 
 Experiments that were performed for optimizing FN concentration and media 
composition were carried out on glass coverslips. FN was diluted in distilled water to 
desired concentrations of 10 µg/cm2, 5 µg/cm2, and 2 µg/cm2 and adsorbed onto 
coverslips for 1 hour. HCASMCs were seeded onto coverslips of different FN 
concentrations at a density of 25,000 cells/coverslip and cultured in SmGM for 2, 4 or 7 
days. For growth media experiments, HCASMCs and HCAECs were seeded at densities 
of 25,000 cells/coverslip and 20,000 cells/coverslip, respectively, onto substrates of 5µg 
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FN/cm2. HCASMCs were cultured for 4 days while HCAECs were cultured for 2 days in 
media compositions of: pure EGM, pure SmGM, or 1 part EGM and 1 part SmGM.     
 
3.2.6 2D Culture for RT-PCR  
 
For RT-PCR work, cultures were carried out on 24-well treated polystyrene tissue 
culture dishes. Culture wells were first coated with 5 µg/cm2 of FN diluted in HBSS. For 
monocultures, HCASMCs were seeded at a density of 1.7x104 cells/well and cultured for 
48 hours with 5 µg/ml of Jagged1 protein or 10 µL/well of Jagged1/IgG-immobilized 
Dynabeads. For co-cultures, HCASMCs were seeded at a density of 1.7x104 cells/well 
and cultured for 48 hours in SmGM. HCAECs were then seeded at a density of 1.7x104 
cells/well over the HCASMC layer and cultured for an additional 48 hours in co-culture 
media. Co-culture media consisted of SmGM and EGM at a 1:1 ratio. 
 
3.2.7 3D Co-culture of HCASMCs and HCAECs on PCU scaffolds 
 
HCASMCs were seeded onto the scaffold discs at varying initial densities 
depending on the experiment and allowed sufficient time for attachment in a 37°C, 5% 
CO2 incubator. After attachment, scaffolds were transferred to a 24-well culture plate 
with 2 ml of SmGM and cultured at 37°C, 5% CO2 for 48 hours. Matrigel was solubilized 
in serum-free growth media and added over the HCASMC layer (for co-cultures) or over 
bare scaffolds (for HCAEC monocultures) to promote HCAEC attachment. The Matrigel 
solution was adsorbed for one hour at 37°C just prior to HCAEC seeding in a 96-well 
plate. HCAECs were seeded onto scaffolds containing HCASMCs or onto Matrigel-
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adsorbed scaffolds and incubated at 37°C and 5% CO2 for three hours to allow cell 
attachment. Scaffolds were then transferred back to a 24-well dish with 2 ml of growth 
media (EGM for EC monocultures or SmGM and EGM at a 1:1 ratio for co-cultures) and 
cultured for an additional 48 hours. 
 
3.2.8 Immunofluorescence Staining and Fluorescence Microscopy of 2D 
cultures 
 
 Cell cultures from FN concentration and growth media experiments were stained 
for F-actin filaments prior to image analysis. Cells were fixed to their coverslips for 10 
minutes using freshly prepared 2% paraformaldehyde and washed 3 times with 1x 
phosphate buffered saline (PBS). A solution of 0.1% Saponin was applied for 5 minutes 
to permeabilize the cell membranes. Following 3 washes in 1 x PBS, samples were 
incubated in Alexa Fluor® 488 Phalloidin diluted (1:50) in 1% BSA/PBS for 1 hour. 
Finally, cells were washed 3 times using 1 x PBS on the first and third washes and 1 x 
Hoechst 33342 (10ug/ml) on the second wash. Coverslips were mounted onto microscope 
slides using Vectashield as a mounting medium and were sealed using nail enamel. 
Fluorescence images were captured using a Leica CTR Mic fluorescence microscope (Hg 
bulb) and Openlab software.  
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3.2.9 Immunofluorescence Staining and Laser Scanning Confocal 
Microscopy of 3D cultures 
 
Post-culture immunostaining was performed to allow for visualization of cell 
organization and morphology on 3D scaffolds. SMCs were live-stained using CTG at a 
concentration of 10 µM in serum-free media for 45 minutes. Following two 30-minute 
incubations in SmGM (to rinse out the unincorporated dye and by-products),  a thin 
coating of Matrigel was applied and HCAECs were seeded and cultured for 48 hours as 
described above. Cells were fixed using a 4% solution of paraformaldehyde, 
permeabilized in 0.5 % Triton X-100 and washed three times with 1 x PBS. Long-term 
SMC monocultures were stained as described for 2D cultures above. Co-cultured cell-
scaffold constructs and HCAEC-scaffold constructs were incubated in 1% BSA/PBS with 
VE-cadherin antibody (1:50 dilution) for one hour followed by three washes in 1 x PBS. 
Scaffolds were then incubated in Alexa Fluor® 568-conjugated secondary antibody for 
one hour, washed three times with 1 x PBS and incubated with Hoechst 33342 (10 µg/ml) 
for 5 minutes to label the nuclei of all cells. Samples were mounted on glass microscope 
slides in a mounting medium composed of glycerol and water (glycerol:water, 9:1v/v). 
Spacers were used to construct elevated wells in which the scaffolds were contained; 
wells were sealed using coverslips and nail enamel. A Zeiss LSM 410 confocal 
microscope (Carl Zeiss, Germany) equipped with argon/ neon and UV lasers was used for 
imaging the samples. 3D image stacks were created by taking serial optical slices at 
regular increments through the samples. 
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3.2.10 Separation of HCAEC from Co-culture 
 
In order to examine the individual contributions of each cell type toward protein 
expression in co-culture, anti-PECAM conjugated Dynabeads were employed to separate 
the HCAECs from the HCASMCs. First, cells were recovered from scaffolds or culture 
plates by incubating in a 0.25% Trypsin/EDTA solution at 37°C for 5 minutes. This 
method has proved effective in the past for cell recovery from PCU scaffolds2. Scaffolds 
or culture plates were then rinsed several times with a low serum content-buffer (5% fetal 
bovine serum in 1 x PBS) to neutralize the trypsin activity. The trypsinized cell 
suspension was centrifuged for 5 minutes at 21°C and the pellet was re-suspended in 
0.1% BSA/PBS. Washed Dynabeads (25 µL/108 HCAECs) were mixed with the cell 
suspension and rotated at 4°C for 20 minutes to facilitate attachment to HCAECs. 
Following incubation, samples were placed in a magnet to separate the bead-bound 
HCAECs from the supernatant (HCASMC). The supernatant was collected and the bead-
bound cells were rinsed and magnetized three more times to increase the separation 
efficiency. For protein extraction, the bead-bound HCAECs and supernatant 
(HCASMCs) were immersed in sodium dodecyl sulfate (SDS) sample buffer after 
centrifugation. For RNA extraction, the bead-bound HCAECs and the supernatant 
(HCASMCs) were centrifuged and resuspended in TRIzol® Reagent. 
 
3.2.11 Jagged1/Fc Protein Immobilization to Dynabeads 
 
Protein G Dynabeads were washed 3 times with PBS (pH 7.4, 0.02% Tween) and 
mixed with 5 µg of human Jagged1/Fc chimera protein in the original bead volume. The 
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mixture was incubated for 10 min at room temperature on a rotating device and the 
Jagged1-immobilized beads were washed 3 times with PBS. As a control of Jagged1/Fc 
chimeric protein, beads were incubated with human IgG solution (5 µg/ml) at the same 
conditions with those used for Jagged1 binding. This control addresses the effect of the 
Fc fragment of Jagged1 for any possible non-specific effects of the Fc protein. Beads 
were added to cell cultures at a concentration of 10 µL/well. 
 
3.2.12 Transfection of HCAEC with Jagged1 siRNA 
 
Prior to transfection, HCAECs were passaged in antibiotics-free growth media 
such that they would be at 50% confluence at the time of transfection. 200 pmol of 
control siRNA or Jagged1 siRNA was diluted in 1 ml of Opti-MEM reduced serum 
medium. Each of these solutions was then mixed with another 1 ml of Opti-MEM 
reduced serum medium containing 20 µL of Lipofectamine™ RNAiMAX. Solutions were 
incubated at room temperature for 20 minutes before being added to a culture dish of 
50% confluent HCAECs. Following 24 hours in a 37°C, 5% CO2 incubator, cells were 
trypsinized and seeded onto either bare scaffolds or scaffolds containing HCASMCs. 
Following the 48 hour co-culture period, cells were harvested and lysed to test the 
transfection efficiency and protein expression levels. 
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3.2.13 RNA Isolation and Quantitative Real-time PCR Analysis 
  
Real-time polymerase chain reaction (PCR) combined with reverse transcription 
was used to quantify messenger RNA of Notch3, SM-α-actin and calponin in HCASMCs 
grown on 2D surfaces. Total RNA from HCASMCs was isolated using TRIzol® Reagent 
following the manufacturer’s protocol. Complementary DNA was synthesized using 1 µg 
of total RNA primed with oligo(dT)12-18 as described in SuperScript™. Conventional 
reverse transcription PCR was used to test primer specificity by running PCR for 40 
cycles at 95°C for 20 s and 52°C for 1 min. Quantitative real-time PCR was conducted in 
10 µL reaction volumes, using a Chromo4 Real-time Thermal Cycler and gene 
expression of human Notch3, SM-α-actin, calponin and glyceraldehyde3-phosphate 
dehydrogenase (GAPDH) were then determined with iQ™ SYBR® Green Supermix 
according to the recommended protocol of the manufacturer. Notch3 forward primer, 5'-
CCT AGA CCT GGT GGA CAA G -3', and reverse primer, 5'-ACA CAG TCG TAG 
CGG TTG -3'; SM-α-actin forward primer, 5'-CAA GTG ATC ACC ATC GGA AAT G-
3', and reverse primer, 5'-GAC TCC ATC CCG ATG AAG GA-3'; calponin forward 
primer, 5'-TGA AGC CCC ACG ACA TTT TT-3', and reverse primer, 5'-GGG TGG 
ACT GCA CCT GTG TA-3'; GAPDH forward primer, GGT GGT CTC CTC TGA CTT 
CAA CA, and reverse primer, GTT GCT GTA GCC AAA TTC GTT GT, were used3. 
Cycling parameters were optimized as follows: denaturation 95°C (10 s), gradient 
annealing 50°C/65°C (10 s), extension 72°C (30 s), and running for 39 cycles.Notch3, 
SM-α-actin and calponin gene expressions in HCASMCs were normalized to GAPDH 
with at least three repeats per experimental group and expressed as relative ratios using 
the Gene Expression Macro analysis software. 
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3.2.14 Protein Extraction and Western Blot  
 
Expression levels of Jagged1, Notch3, SM-α-actin and calponin in 3D cultures 
were evaluated using Western blotting. Scaffolds from different culture conditions were 
incubated in 0.25% Trypsin/EDTA for 5 minutes at 37oC. The trypsin solution was 
pipetted repeatedly into the scaffolds to recover cells after which the cells were 
centrifuged and collected. Cells from co-culture were separated using anti-PECAM 
conjugated Dynabeads (as described above) while cells from monocultures were 
immediately immersed in 100 µL of SDS sample buffer containing 5% (v/v) β-
mercaptoethanol. Lysates were micro-centrifuged and the protein concentrations were 
determined using 660 nm Protein Assay. 20 µg/well of protein was loaded and separated 
by 10% SDS-polyacrylamide gel electrophoresis for 50 minutes then subsequently 
transferred overnight at 4°C onto a nitrocellulose membrane while submerged in a Tris-
glycine buffer. Ponceau S stain was used to verify proper transfer. Membranes were then 
blocked with 5% non-fat dry milk in 1 x PBS for one hour and incubated in primary 
antibodies (diluted in 5% non-fat dry milk in 1 x PBS): anti-SM α-actin (1:1000 dilution), 
anti-calponin (1:1000 dilution), anti-Jagged1 (1:200 dilution), anti-Notch3 (1:200 
dilution) and anti-GAPDH (1:2000 dilution) for 2 hours. After incubation with HRP-
conjugated secondary antibodies for 45 minutes, membranes were incubated for 5 
minutes in SuperSignal®West Pico Chemiluminescent substrate. Bio-Rad’s ChemiDoc™ 
XRS+ System (Mississauga, ON, Canada) was used to image the membranes and blots 
were quantified using Image Lab™ software. 
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3.2.15 Statistical Analysis 
 
Quantified data for RNA and protein expression levels were plotted and analyzed 
using GraphPad Prism 5. Values were normalized against GAPDH and graphs were 
constructed using data from at least three independent experiments. Quantified data are 
presented as mean ± standard deviation and were statistically analyzed by one-way 
ANOVA followed by Tukey’s post hoc test to compare differences between two groups. 
Values of p < 0.05 were considered to be statistically significant. 
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Chapter 4 – Results and Discussion 
 
4.1 Gene Expression Levels in HCASMCs and HCAECs from 
2D Co-culture 
 
One of the main objectives of this study was to examine possible phenotype 
changes that HCASMCs may undergo in the presence of HCAECs. Before introducing 
HCAECs into co-culture studies with HCASMCs, we conducted a series of experiments 
to determine if an EC secreted molecule, Jagged1, exogenously added to HCASMC 
cultures could affect the regulation of gene expression leading to phenotype modulation. 
To this end, a series of experiments that analyzed gene expression in HCASMCs cultured 
in the presence of soluble Jagged1, immobilized Jagged 1 and EC-surface expressed 
Jagged1 were compared.  
Although it has been detected in arterial SMCs, Jagged1 is a transmembrane 
protein that is predominantly expressed by VECs1-4 while the Notch3 receptor is a 
membrane-bound protein that is expressed in VSMCs. Binding of the Notch receptor 
with its ligand (Jagged1) results in activation of the Notch signaling pathway and 
ultimately prompts differentiation in VSMCs5. A host of in vivo and in vitro studies have 
demonstrated a vital function of Jagged1 in regulating SMC differentiation2,5-9. These 
studies formed the basis for our examination of gene expression levels of Notch3 and 
various differentiation markers in HCASMCs and HCAECs. 
Several reports have demonstrated the ability of soluble Jagged1 to induce 
differentiation of keratinocytes10-11, mesenchymal stem cells into cadriomyocytes12 and 
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cochlea progenitor cells into primary sensory cells13. Other studies have shown 
contrasting findings in which Notch ligands in immobilized form is a requirement for 
inducing differentiation14-17. Alternatively, considering that the Jagged1 ligand is an EC 
transmembrane protein, signaling is generally assumed to be mediated by cell-cell 
contact18; hence VSMC phenotype modulation may be contact-dependant19-20. If soluble 
Jagged1 was able to induce contractility in HCASMCs then it could be delivered to cells 
via culture media during vascular tissue engineering. If, on the other hand, Jagged1-
immobilized beads produced a significant enhancement of Notch3 and SMC contractile 
gene expression, Jagged1-functionalized scaffolds could be designed. Given the 
complexity of 3D culture systems a 2D model was chosen to simplify and ensure delivery 
of these molecules to cultured cells.  
 
4.1.1 Effects of Soluble and Immobilized Jagged1 on HCASMC Gene 
Expression  
 
In the first of these experiments, HCASMCs were cultured on a 2D substrate of 
tissue culture–treated polystyrene for 48 hours in media containing 5 µg/ml soluble 
Jagged1. This was followed by RNA extraction for RT-PCR as described in Chapter 3. 
The role of soluble Jagged1 in HCASMC phenotype modulation was assessed through 
examination of Notch3, SM-α-actin and calponin gene expression levels. SM-α-actin and 
calponin are early-to-mid stage SMC differentiation markers that are known to be 
upregulated in the contractile phenotype21-22. SM-α-actin was also chosen because it is a 
direct target of Notch activity23-24. Results from Figure 4.1A-C indicate that soluble 
Jagged1 was unable to produce any significant changes in terms of HCASMC gene 
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expression compared with the controls in which HCASMCs were cultured in pure SmGM 
as well as a second condition consisting of HCASMCs cultured in IgG-supplemented 
SmGM (p>0.05). The IgG control accounts for any non-specific effects of the Fc-
fragment found on the Jagged1 protein.  These results suggest that Jagged1 protein in and 
of itself is not sufficient in promoting Notch signaling activity.  
 
Figure 4.1: Effect of Soluble Jagged1 and Immobilized Jagged1 on Notch3 and HCASMC 
Gene Expression. HCASMCs were culture for 48 hours with soluble Jagged1 (A-C) or Jagged1-
immobilized protein G beads. Gene expression levels of Notch3 (A, D), SM-α-actin (B, E) and 
Calponin (C, F) are shown. The asterisks indicate statistically significant difference (p < 0.05). In 
Figs A-C, control refers to HCASMCs cultures in pure SmGM.  
 
Since soluble Jagged1 did not affect HCASMC gene expression, the role of 
Jagged1 immobilized to the surface of protein G beads could influence Notch and SMC 
contractile gene expression. The reasoning behind this was that the bead surface could 
potentially mimic a signaling cell surface by presenting the Jagged1 ligand to adjacent 
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HCASMCs. Furthermore, it would provide insight into biomaterial-mediated Notch3 
signaling. Results from Figure 4.1D-F show that although Jagged-immobilized beads 
were able to significantly upregulate Notch3 gene expression in HCASMCs (p<0.05), a 
corresponding increase in contractile gene expression was not detected (p>0.05) which is 
presumably due to an already high basal level of contractile gene expression. This 
suggests that other biochemical or structural cues  that are not offered by the Jagged1-
immobilized beads  may be necessary to activate the signaling cascade that results in 
HCASMC differentiation. Alternatively, the upregulation of the Notch3 gene may not 
translate into Notch3 protein expression which may be elementary in inducing the 
contractile phenotype in HCASMCs. Nonetheless, these results indicate the need for a 
model that recapitulates the interactions between Jagged1 and Notch3 in vivo. 
Complementary experiments that support these results are shown in our previous 
publication25. The general finding was that Jagged 1 in soluble or immobilized form is 
not capable of producing an increase in HCASMC contractile protein expression.  
 
4.1.2 Effect of HCAEC Jagged1 Knockdown on HCASMC Gene 
Expression 
 
The next step to investigate Notch-induced gene expression in 2D cultures was to 
examine the effect of EC-bound Jagged1 on Notch activity.  In order to do this, a direct 
co-culture model was chosen to allow for heterotypic cell-cell contact. This type of 
interaction has been shown to be a requirement for Notch3 activation and subsequent 
SMC contractile marker expression2. Jagged1 was knocked down in HCAECs using 
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siRNA and was followed by 48hours of co-culture of HCAECs with HCASMCs. Cells 
were separated using PECAM-coated magnetic beads prior to RNA extraction as 
described in Chapter 3. Results are shown in Figure 4.2 below. 
 
Figure 4.2: Effect of siRNA knockdown of Jagged1 on gene expression levels in co-culture. 
Expression levels of Notch3 (A) and SM α-actin (B) in HCASMCs and HCAECs co-cultured for 
48 hours and subsequently separated using PECAM-conjugated magnetic beads. Asterisks 
indicate statistically significant data (p<0.05).  
 
As is shown in Figure 4.2, siRNA knock down of Jagged1 in HCAECs significantly 
downregulated the expression of Notch3 in HCASMCs in co-culture (p<0.05). This was 
further translated into a significantly lower expression of SM-α-actin in HCASMCs 
suggesting a direct link between HCAEC-bound Jagged1 and HCASMC differentiation 
(p<0.05). Unlike immobilized Jagged1, which was able to upregulate the expression of 
Notch3 in HCASMCs but failed to upregulate contractile marker expression, HCAEC-
bound Jagged1 appears to have a direct effect on the expression of Notch3 and SM-α-
actin in HCASMCs. Complimentary experiments were performed to examine the effects 
of HCAEC-bound Jagged1 on HCASMC protein expression. The results, shown in our 
69 
 
 
recent publication25, were in agreement with the gene expression data; that is, direct 
heterocellular cell-cell contact is necessary for HCASMC differentiation via Notch3 
signaling. This in turn validates the need for a direct co-culture system in 3D for studying 
the controlled modulation of HCASMC phenotype. Based on these exploratory 
experiments, a 3D culture approach for SMCs phenotype modulation is now needed.  
 
4.2 Scaffold Characterization 
 
Scaffolds were fabricated using a SCPL method by the application of pressure to 
force polymer solution through a tightly packed porogen bed. SCPL was used because it 
allows for easy control of pore size and porosity26. The polymer and porogen of choice 
were PCU and NH4CL, respectively. Polyurethanes are among the various natural and 
synthetic polymers that are commonly used for tissue engineering applications. With 
regard to vascular tissue engineering, degradable polymers are generally favoured as 
scaffolding materials; however, traditional polyesters such as PLLA, PGA and their 
copolymers, although promising, tend to form acidic degradation products in vivo that 
can impact VSMC phenotype27 and cause inflammation28. Protein hydrogels composed of 
natural polymers such as collagen type I29, fibrin30-31 and elastin32 have displayed a high 
degree of biocompatibility but generally lack the necessary mechanical properties that are 
required of a blood vessel substitute33 even after weeks of in vitro maturation34. 
Furthermore, biodegradable scaffolds may prematurely degrade in vivo before sufficient 
graft remodeling has taken place, leading to weak neotissue35-36. In this respect, biostable 
scaffolds are advantageous since they have the capacity to carry mechanical loads 
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enabling the graft to function immediately upon implantation  a requirement for 
engineered vascular tissues. Biostable polyurethane elastomers have been extensively 
used for biomedical and vascular applications due to their acceptable biocompatibility 
and excellent mechanical characteristics37-41. PCU was utilized in this study based on (1) 
its proven elasticity42-44, (2) the fact that there are no degradation products that can 
adversely modulate VSMC behavior and interfere with evaluation of VSMC phenotype27, 
(3) the ability to recover cells for biochemical analysis without contamination by scaffold 
fragments and (4) its capacity for supporting the growth of vascular cells38,45-46. Before 
commencing cell culture studies it was important to first verify the structure of the 
scaffolds in use since scaffold geometry and pore structure may significantly impact cell 
infiltration and communication46. The structure of the fabricated PCU scaffolds, show in 
Figure 4.3, was highly porous, uniform and interconnected.  
 
 
Figure 4.3: Scanning electron micrographs of porous PCU scaffolds. Scanning electron 
micrographs of scaffolds fabricated from PCU with porogens ranging from 180-212μm in 
diameter; A) Arrow indicates scaffold edge, pores are highlighted in yellow; B) Arrows indicate 
interconnecting pores. Scale bar, 250µm. 
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Since the pores are defined by the x, y and z planes, it was difficult to take an 
accurate measurement of pore size based solely on qualitative analysis. However, 
because PCU scaffolds fabricated from the SCPL method were extensively studied by 
Mequanint and co-workers46-47 it was not necessary to analyze the pores in depth. The 
pores outlined in Figure 4.3A gives values ranging from 142µm to 254µm for pore 
diameter. There are several possible reasons for the variance in pore size. Firstly, the 
isotropy of the pore dimensions can be attributed to the irregular shape of the ground 
NH4Cl particles46. Particles having a narrow diameter in one plane but a large diameter in 
another plane may easily become trapped in the sieve or pass right through depending on 
the particle’s orientation during sieving. As a result, some pore sizes fall outside the 
expected range of 180-212µm. Secondly, evaporation of the DMF solvent likely results 
in volume reduction of the scaffold struts; consequently, the pore size increases. The 
reasoning behind the choice of porogen size was two-fold. First, it has been identified 
that the optimal pore size range for vascular tissue engineering applications is 150-
300µm48. Second, a large surface area to volume ratio is necessary for the recruitment 
and maintenance of a dense cell population38,49 and a reduction in pore size results in a 
higher surface area to volume ratio45. Thus, particles were chosen from the lower end of 
the range to meet both of the above criteria. Although porosity calculations were not 
performed in this study, previous work in our laboratory has shown that PCU scaffolds 
fabricated using NH4Cl and SCPL result in structures with 84% porosity  which falls 
into the optimal range of 80-90%38. In comparison to those scaffolds, those used in this 
study have thinner struts and so the porosity value may actually be higher. Scaffold 
architecture has been identified as an important factor in facilitating cell-cell and cell-
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matrix communication and in providing the necessary mechanical strength. High porosity 
and large interconnected pores promote tissue ingrowth, vascularization, interstitial fluid 
flow and diffusion of nutrients and waste50-52. Furthermore, cell migration is discouraged 
if there are no interconnecting pores53 and a lack of structural uniformity produces 
inferior mechanical properties54. Since the porogen particles were ground and sieved into 
a narrow size range, a relatively uniform pore size could be achieved. Microporosity is 
another critical property to be considered. A delicate balance must be struck to limit the 
microporosity to a reasonable value in order to retain the mechanical integrity of the 
scaffold. Micropores are essential in allowing capillary ingrowth during in vivo 
remodeling54. On the other hand, an overabundance of micropores  specifically those 
that do not link the macrovoids  can detract from the mechanical strength of the 
scaffold. This is crucial in the case of vascular grafts since compliance and structural 
integrity are imperative48. SEM images (Figure 4.3) of scaffolds fabricated for this study 
show the presence of micropores on the order of 16 µm or less. These pores should 
significantly improve the formation of a 3D tissue by facilitating cell-cell 
communication, mass transfer and capillary infiltration55. Studies previously conducted 
by our group demonstrated that PCU scaffolds fabricated using NH4Cl and employing the 
SCPL method have mechanical properties comparable to that of native blood vessels47. 
Therefore, the degree of microporosity seen here may not adversely affect the strength of 
the scaffold. The relative rate at which solvent is exchanged for nonsolvent during 
scaffold fabrication determines the extent of micropore formation48; so if required, 
microporosity can be controlled through careful selection of solvent/ nonsolvent pairs. As 
demonstrated by these findings, scaffolds constructed for the current study exhibit the 
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qualities that are essential for vascular tissue engineering applications: they are 
structurally uniform, highly porous and highly interconnected. 
 
4.3 Optimizing Conditions for Co-Culture 
 
4.3.1 Effect of Varying FN Concentration on HCASMC Attachment and 
Proliferation 
 
Cell adhesion plays a crucial role in guiding cell fate56. In order to promote 
HCASMC adhesion, PCU scaffolds were made bioactive through surface modification 
with FN. In native blood vessels FN is a glycoprotein of the ECM that serves many 
functions. In conjunction with the other components of the ECM, it provides mechanical 
support and anchorage for the cells, participates in mechanotransduction and guides the 
biological functions of the tissue under both physiological and pathological 
conditions47,57-58. FN can also bind many ECM molecules into a continuous network and 
binds cells through interactions between the α5β1 and αvβ3 integrins (transmembrane 
receptors) and the RGDS (Arg-Gly-Asp-Ser) sequence on the FN molecule59. A host of in 
vitro culture studies have shown a correlation between FN and SMC phenotype60-63. 
Indeed the presence of a FN substrate shifts SMCs into a synthetic phenotype by 
enhancing cell attachment and spreading combined with the formation of an extensive 
rough endoplasmic reticulum and large Golgi complex and the loss of myofilaments62. 
FN has also shown to have superior results as an adhesion substrate when compared with 
others such as vitronectin61. There is also evidence that FN promotes this behavior in 
SMCs on 3D substrates. Grenier et al.47 observed increased infiltration, proliferation and 
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collagen deposition by HCASMCs on PCU scaffolds compared with uncoated scaffolds. 
This was the primary justification for functionalizing PCU scaffolds prior to cell culture. 
The secondary purpose for the addition of FN was to partially recreate the ECM of the 
arterial media- since the short culture duration is likely insufficient for the formation and 
deposition of an extensive network of ECM molecules. As the 3D geometry of the 
scaffold makes it difficult to assess cellular morphology and adhesion characteristics, a 
2D substrate was instead used to determine the optimal FN density for enhancing 
HCASMC attachment. The range of FN concentrations was chosen based on values 
reported in literature64-65.  
HCASMCs were cultured for 2, 4 or 7 days on FN concentrations of 2, 5 or 10 
µg/cm2. Cells were more sparsely distributed on a substrate of 2 µg FN/cm2 (Figure 4.4 
A-C) as compared with those cultured on substrates of 5 and 10 µg FN/cm2 (Figure 4.4 
D-I) as evidenced by the black areas (bare coverslip). This is likely due to incomplete 
coverage of the glass coverslip by FN molecules resulting in cells adhering specifically at 
sites where the adhesion sequence is detected by integrins. All subsequent experiments 
for HCASMC monocultures and co-cultures employed FN as a basal adhesion protein at 
a concentration of 5 µg/cm2 or 5 µg/scaffold.  
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Figure 4.4: HCASMCs grown on varying amounts of FN. Representative Fluorescence 
microscopy images of HCASMCs cultured on FN coated glass coverslips. HCASMCs were 
cultured over 2 (A, D, G), 4 (B, E, H), and 7 (C, F, I) days on 2 (A-C), 5 (D-F) or 10 (G-I) 
µg/cm2 FN coated coverslips. F-actin is stained with Alexa Fluor®488 Phalloidin (green) and 
nuclei are stained with Hoechst 33342 (blue). Scale bar, 10µm. 
 
It has been acknowledged that scaffold surface area is not 1 cm2 and that 5 µg/cm2 
is not analogous to 5 µg/scaffold, nevertheless, it has been proven effective by others21. 
Since porosity measurements were not calculated, the exact surface area that is available 
for FN adsorption is unknown; as a preliminary experiment it was not necessary to 
investigate this topic further.  
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4.3.2 Effect of Growth Media Composition on HCASMC and HCAEC 
Viability 
 
In addition to determining the optimal FN concentration it was also necessary to 
establish the optimal media compositions for maintenance of cells in co-culture. ECs and 
SMCs have different nutrient requirements, hence the need for specific nutrient 
composition for growth during cell culture. During co-culture of these cells, it was 
imperative that the media used in maintaining co-cultures not compromise the viability or 
change the behavior of either cell type. Therefore, monocultures were conducted on 2D 
substrates of FN-coated glass coverslips for identifying media composition. 
As shown in Figure 4.5, HCASMCs exhibited a spindle-like morphology and 
were able to maintain a dense population irrespective of media composition. On the other 
hand, HCAECs appear to be more stringent in their requirements. HCAECs from panels 
D through F in Figure 4.5 displayed a cobblestone morphology which is indicative of a 
healthy phenotype65. However, in panel F, which shows HCAECs cultured in SMC-
specific media, HCAECs failed to achieve a high enough density to form cell-cell 
junctions. Junction formation is critical in achieving two distinct cell layers in co-culture. 
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Figure 4.5: HCASMC and HCAEC monocultures in varying growth media compositions. 
HCASMCs (A-C) and HCAECs (D-F) were cultured alone for 4 and 2 days respectively, in EGM 
(A, D), 1 part EGM and 1 part SmGM (B, E) or SmGM (C, F). F-actin is stained with Alexa 
Fluor®488 Phalloidin (green) and nuclei are stained with Hoechst 33342 (blue). Scale bar, 20µm. 
 
HCASMCs may tend to shift to a synthetic phenotype, migrate through the voids 
and disrupt the HCAEC layer thereby mimicking the injury response commonly seen 
during atherosclerosis. In an engineered vascular substitute this type of cell behavior 
would render the construct dysfunctional and upon implantation would result in intimal 
hyperplasia, stenosis and graft failure66. The underlying cause for decreased HCAEC 
growth in SmGM is likely explained by the absence of essential media components that 
are found in EC-specific media (EGM). Examination of the constituents of both SmGM 
and EGM reveals that vascular endothelial growth factor (VEGF), recombinant insulin-
like growth factor-1 (IGF-1), ascorbic acid and heparin are absent in SmGM. VEGF is 
known to have potent mitogenic and angiogenic effects on ECs, a process which is 
strongly mediated by heparin67-68.  In vitro studies of human umbilical vein ECs have 
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suggested that IGF-1 molecules present in the blood in vivo migrate through the 
endothelium and act on the subendothelial ECM to have a mitogenic and growth 
promoting action on ECs. Furthermore, these studies suggest that IGF-1 may be involved 
in the survival and stability of ECs69-70. Finally, the role of ascorbic acid is in the 
regulation of nitric oxide (NO) bioactivity. In vivo, NO is produced by ECs and maintains 
them in a healthy state. It is also critical for proper control of vascular tone, arterial 
pressure, platelet adhesion and SMC proliferation. In fact, the manifestation of vascular 
disease may in part be attributed to impaired NO production71. Clearly these components 
are vital in sustaining ECs in a healthy proliferative state. Therefore, their absence in 
SmGM is the likely cause for reduced HCAECs density in cultures sustained in this 
media. These components are also required in the co-culture media to ensure that 
HCAECs spread to form a continuous monolayer over the HCASMCs to create a 
structure that mirrors the arterial wall. Thus, it was decided that all subsequent co-
cultures would be sustained in growth media composed of equal parts SmGM and EGM 
since under this condition both HCASMCs and HCAECs were able to proliferate and 
maintain healthy morphologies. 
 
4.3.3 Long-term HCASMC Monoculture on PCU Scaffolds 
 
The next stage of the study involved examining the interactions between 
HCASMCs and PCU scaffolds. In vitro tissue maturation is generally a lengthy process 
that spans several weeks. In order for the co-culture model being developed to be 
applicable in the fabrication of engineered vascular substitutes, PCU scaffolds must be 
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able to support the growth of vascular cells over long periods of time. Specifically they 
must enable VSMCs to maintain a healthy state that encourages cell migration, expansion 
and ECM deposition. This process should culminate in the formation of a vascular media 
that closely resembles the tunica media of the coronary artery. VECs can then be 
incorporated to form the tunica intima and regulate the activities of the underlying VSMC 
layers. Cell retention on PCU scaffolds is also a good indicator of how these cells would 
behave in an in vivo environment; detachment of cells upon implantation may severely 
compromise the function of a tissue engineered vascular substitute. In view of this, long-
term HCASMC monocultures were investigated.  
Figure 4.6 shows the degree to which HCASMCs infiltrated PCU scaffolds over 
an 8 and 16 day period. Z-sections were taken at 20 µm increments through the depth of 
the scaffold and selected slices are shown at 0 µm, which corresponds to the seeding 
surface, 40 µm and 140 µm. 
80 
 
 
 
Figure 4.6: Serial optical sections of long-term HCASMC cultures on PCU scaffolds. Images 
of HCASMCs cultured on PCU scaffolds for 8 (A-C) and 16 (D-F) days at depths of 0 µm (A, D), 
40 µm (B, E) and 140 µm (C, F) from the seeding surface. F-actin is stained with Alexa 
Fluor®488 Phalloidin (green) and nuclei are stained with Hoechst 33342 (blue). Scale bar, 100 
µm. 
 
As shown above, HCASMCs adhered to the scaffold struts initially and over time 
extended cytoplasmic projections across the entire pore diameter. After 16 days of 
culture, the cell population dramatically increased and pores were no longer visible. 
Interestingly, a majority of the cell migration and proliferation took place within 40 µm 
of the seeding surface of the scaffold. It is possible that the adsorbed FN molecules were 
focused within this section of the scaffold resulting in increased initial HCASMC 
attachment at these locations. Additionally, because static culture conditions were 
utilized, the nutrition and oxygen content of the medium likely becomes depleted with 
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increasing depth through the scaffold, thereby affecting cell growth at greater depths. 
Although cell infiltration in the vertical direction was slow, a significant difference was 
observed between day 8 and day 16 of culture; cell density at 140 µm was much greater 
after 16 days as compared with 8 days of culture. Maximal cell penetration at 16 days of 
culture was close to 200 µm (Figure Appendix A1); however, only a few cells could be 
seen. A study by Grenier et al.45 showed that HCASMCs cultured on PCU scaffolds 
achieved a maximum depth of 300 µm after 14 days of culture. Similar to the current 
results, the majority of the cell population resided close to the seeding surface of the 
scaffold and only one or two cells could be seen at a depth of 300 µm. However, their 
presence could not with certainty be attributed to active cell migration45. For instance, 
during cell seeding, those cells that show delayed attachment may fall through the pores 
to a greater depth within the scaffold before they extend adhesion processes. In the 
current study, images were taken at relatively small intervals so the path of cell migration 
could be mapped. This confirmed that the presence of cells at 200 µm was a direct result 
of active cell migration from the focal planes above. It is possible that some cells were 
present at depths greater than 200 µm, but due to limitations placed by the scaffold 
thickness or the mounting procedure used, in-focus images could not be taken beyond 
this point.  
A previous work by our research group46 showed that PCU substrates have the 
capacity to support HCASMCs for a period of at least 14 days. In this cited study, 
interactions between HCASMCs and PCU films were examined to eliminate any effects 
of 3D geometry that PCU scaffolds may impart. Results indicated that HCASMCs do not 
attach as readily to bare PCU as compared with Matrigel-adsorbed PCU. Furthermore, 
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after 7 days of culture bare PCU films remained sparse46. In a subsequent study45, 
interactions between HCASMCs and PCU scaffolds were investigated. In agreement with 
the prior results, cells did not attach to bare PCU scaffolds as readily as they did to 
Matrigel- coated PCU scaffolds45. Contrary to these results, in the present study, 
HCASMCs showed no aversion to bare PCU scaffolds. In fact, examination of Confocal 
images showed no noticeable differences in cell density between bare PCU scaffolds and 
FN-coated scaffolds after 48 hours of culture (Figure Appendix A2). However, FN was 
still employed based on 2D culture results. Moreover, Lin et al.21 noted that HCASMCs 
readily adhere to bare PCU scaffolds but do not achieve as dense population as they do 
on FN-coated PCU scaffolds after 7 days. Therefore, although noticeable differences 
could not be observed over the short culture duration used in the current work, the FN 
coating would likely have a long-term effect. Prior to HCASMC seeding, FN-adsorbed 
scaffolds were kept hydrated in HBSS to increase their hydrophilicity  which is known 
to improve VSMC adhesion, spreading and proliferation72. 
Overall, these results reiterate the value of using PCU scaffolds for vascular tissue 
engineering. Their ability to support long term growth of HCASMCs is elemental in the 
creation of vascular grafts and is a prerequisite for the successive seeding of HCAECs. 
This particular experiment was conducted under static conditions using a relatively low 
cell density. The seeding of a high HCASMC density and transition to dynamic culture 
conditions in a bioreactor would likely enhance and expedite their growth and synthesis 
of ECM molecules by improving oxygen, nutrient and waste exchange and by providing 
biomechanical cues. In fact experiments involving dynamic culture of HCASCMs on 
PCU scaffolds have already been executed with positive results73. 
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4.3.4 Effect of Varying HCASMC and HCAEC Seeding Density on Co-
culture Stability 
 
HCASMCs were seeded at varying densities on PCU scaffolds in order to 
investigate its effect on scaffold coverage and ultimately HCAEC attachment. High cell 
densities were chosen since the culture duration was short and so would not provide 
sufficient time to allow cells to migrate or proliferate extensively. Moreover, low seeding 
densities (less than 1x105 SMCs/scaffold) reported in other studies47,74 were not effective 
in forming a confluent cell layer over the scaffold surface after 4 days of culture so higher 
cell densities were chosen for the present work. HCASMCs cultured alone at three 
different densities for 72 hours on PCU scaffolds are shown in Figure 4.7. 
 
Figure 4.7: HCASMCs cultured at varying initial densities for 72 hours on PCU scaffolds. 
HCASMCs seeded at initial densities of 250,000/scaffold (A,D), 500,000/scaffold (B,E) and 
750,000/scaffold (C,F) shown at 10x (A-D) or 40x (E,F) magnification. Cells are stained with a 
the cytoskeletal marker CTG (green) and Hoechst 33342 (blue) for the nuclei. Arrows indicate 
scaffold edge. Scale bars, 200µm (A-D) and 20µm (E, F). 
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A seeding density of 250,000 cells/scaffold produced scaffolds that were sparse in 
some areas and moderately confluent in others. At 500,000 cells/scaffold the majority of 
the scaffold surface was covered by a confluent layer of cells. Some areas such as the 
scaffold periphery (indicated by arrows in Figure 4.7) had pores that were still visible. 
Upon further magnification (Figure 4.7E) it can be seen that confluent areas consisted of 
a single monolayer of cells. In contrast, scaffolds cultured with 750,000 cells had densely 
packed cells that covered the entire scaffold surface. A corresponding high magnification 
image (Figure 4.7F) shows that cells were tightly packed together and appeared to have 
multiple layers making them indistinguishable from one another. The presence of 
multiple HCASMC layers is also confirmed in Figure 4.8. 
 
Figure 4.8: Serial optical sections of HCASMC cultured on PCU scaffolds. HCASMCs 
seeded at an initial density of 750,000/scaffold and cultured for 72 hours on PCU scaffolds. 
Selected images from a single image stack are shown at depths of 0 µm (A), 40 µm (B) and 80 
µm (C) from the seeding surface. Cells are live-stained with a the cytoskeletal marker CTG 
(green) and Hoechst 33342 (blue) for the nuclei Scale bar, 200 µm. 
 
Panels A through C from Figure 4.8 show cell penetration through the scaffold 
depth. The high seeding density (750,000 SMCs/scaffold) facilitated the formation of 
densely packed layers of cells within (at least) the top 80 µm of the scaffold. In confluent 
85 
 
 
areas cells were aligned in parallel to each other and oriented in coordination with 
neighboring cells regardless of seeding density; that is, cells throughout the entire surface 
seem to be aligned in the same general direction. Interestingly, at low cell densities (such 
as those shown in Figure 4.6) cell orientation was guided by the scaffold struts, whereas 
at high cell densities, cell alignment was self-guided and coordinated with neighbouring 
cells. This created a uniform yet crowded environment rather than clusters of cells that 
were randomly aligned. This rearrangement could be an effort to conserve space as cell 
density increases and to improve intercellular communication. Unfortunately, the 
constituent cells from different cell layers were aligned in different directions (Figure 
Appendix A3) ˗ an issue that would likely be resolved under dynamic culture with 
mechanical stimulation75-77. With respect to morphology, there appeared to be some 
heterogeneity within the scaffold. At seeding densities of 250,000 SMCs/scaffold, sparse 
areas of the scaffold contained cells that had a fibroblast-like/ polygonal appearance 
neighboring cells that had a spindle-shaped appearance. Furthermore, at high seeding 
densities, cells along the seeding surface had a homogenous spindle-shaped morphology 
while cells in the underlying layers had a fibroblast-like/ polygonal morphology (Figure 
Appendix A3). The spindle-shaped and fibroblast-like morphologies are distinguishing 
characteristics of SMCs in the contractile and synthetic phenotypes respectively78.  
Whereas cells in the contractile phenotype show a very low proliferative index, cells in 
the synthetic phenotype are highly proliferative, migratory and lay down an abundance of 
ECM proteins79-80. It is possible that the morphological differentiation is induced by the 
scaffold geometry; however, it is unclear why HCASMCs in the upper levels of the 
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scaffold undergo this differentiation while cells deep into the scaffold remain in the 
synthetic phenotype and continue to populate the scaffold.  
Confocal images of co-cultured HCASMCs and HCAECs are shown in Figure 
4.9. Images are shown deconstructed into their component channels alongside their 
composite images. Cadherin molecules from cell-cell junctions between individual 
HCAECs are shown in red, HCASMCs are stained green and nuclei are stained blue. 
Mild autofluorescence of PCU lends to its visibility in Figure 4.9D and 4.9G. 
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Figure 4.9: HCAECs cultured with varying densities of HCASMCs for 48 hours on PCU 
scaffolds. HCASMCs seeded at initial densities of 250,000/scaffold (A,D,G), 500,000/scaffold 
(B,E,H) and 750,000/scaffold (C,F,I).  HCAEC-cell junctions are stained with VE-cadherin (red) 
and HCASMCs are live-stained with the cytoskeletal marker CTG (green).All nuclei are labeled 
with Hoechst 33342 (blue). All images are at 10x magnification. Scale bar, 200µm.  
 
Intriguingly, HCAECs preferentially adhered to the HCASMCs over the scaffold 
struts. This is evidenced by the fact that areas where the scaffold appears bare in the red 
channel (appears black in images) also appear bare in the green channel (appears black or 
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faint green in images). Bare areas on the scaffold should have molecules of FN adsorbed 
onto their surface and so should promote HCAEC attachment. However, it is possible 
that the ECM molecules produced specifically by the HCASMCs provided a better 
substrate for HCAEC attachment. The HCAECs also seemed to organize themselves into 
a pattern that very closely follows the HCASMC alignment. This is likely due to the 
pattern in which the HCASMC-produced matrix molecules were deposited. Not 
surprisingly then, scaffolds seeded with 750,000 SMCs resulted in full coverage of the 
scaffold surface by HCAECs. Moreover, the HCAECs formed a confluent layer and no 
clusters of cells were observed. This observation is in agreement with results obtained by 
other investigators81-82. Wallace et al.81 reported alignment and arrangement of ECs in a 
similar pattern as the underlying SMCs over which they were cultured.  They found that 
whereas FN adsorbed onto culture dishes was uniform and diffuse, FN synthesized by 
SMCs were organized into fibrils along the cell surface. Therefore, they conjectured that 
the pattern of ECM deposition was responsible for the alignment of ECs with the 
underlying SMCs81. This was later confirmed in a subsequent study82 where they showed 
that the primary protein that controls EC attachment in co-culture is fibrillar FN and is 
mediated by it receptor (the α5β1-integrin complex). It is worth mentioning that co-
cultures on subconfluent HCASMCs (Figure 4.9A, D and G) displayed heterogeneous 
attachment of HCAECs. At higher magnifications these cultures had some areas in which 
HCAECs were well spread out and aligned with the underlying elongated HCASMCs and 
other areas in which HCAECs formed clusters over underlying fibroblast-like 
HCASMCs. Moreover, HCAECs in the latter region: were seen adhering to the scaffold 
struts, were intermixed with the HCASMC population and had ill-defined junctions 
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(Figure Appendix A4). Although the phenotype of the HCASMCs had not been 
confirmed at this point it seems as though the HCAECs preferred to adhere to 
morphologically differentiated HCASMCs with an elongated, spindle-like morphology. 
The pattern of FN deposition by the differentiated HCASMCs versus the synthetic 
HCASMCs is likely responsible for this type of attachment pattern. Chaterji et al.83 
demostrated that differentiated SMCs produce fibrillar FN while proliferating SMCs 
secrete diffuse FN and that this resulted in uniform attachment of ECs to differentiated 
SMCs and clustering of ECs on proliferating SMCs. Other reports in literature suggest 
that uneven topography results in uneven cell spreading and reduced focal adhesions as 
compared with flat surfaces84-85. Together these two factors could account for the 
preferred attachment of HCAECs to the relatively horizontal topography (of elongated 
HCASMC) rather than the scaffold struts. It has also been suggested that the deposition 
of ECM proteins in fibrillar form may be a prerequisite for conserving a quiescent state in 
ECs over a long period of time86. Long-term co-culture stability was not investigated in 
the present study but the observed arrangement of ECs is akin to that observed in stable 
long term co-cultures by other investigators. This suggests that the present 3D co-culture 
model could potentially be sustained for extended periods of time.  
To verify the existence of an EC monolayer, high magnification optical sections 
were taken in the z direction. Images were taken from several different scaffolds to 
ensure reproducibility and are shown in Figure 4.10. Images were taken at the seeding 
surface (0 µm) and at increasing depths through the scaffold (10 and 20 µm). Since the 
HCAECs appear in focus near the seeding surface while the HCASMCs appear in focus 
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further into the scaffold, it is clear that the HCAECs were residing above the HCASMCs. 
In addition, the HCAECs were organized into a confluent monolayer.  
 
Figure 4.10: Serial optical sections of 750,000 HCASMCs and 200,000 HCAECs co-cultured 
for 48 hours. Images taken at depths of 10 µm increments starting at the seeding surface (A,D,G) 
and at increasing depths of 10 µm (B,E,H) and 20 µm (C,F,I). VE-cadherin (red) staining shows 
HCAEC-cell junctions while HCASMCs are stained with a cytoskeletal marker CTG (green). All 
nuclei are labeled with Hoechst 33342 (blue). Scale bar, 20µm. 
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Examination of the bottom right corner of Figure 4.10A shows HCAECs that are in 
focus. Upon inspection of the same area in Figures 4.10B&C it can be concluded that 
there were no HCAECs inhabiting that area at 10 or 20 µm depths. Similar observations 
can be made for all other areas of the images shown in Figure 4.10 thus proving that 
HCAECs were organized into a single monolayer. Junctions between individual 
HCAECs were well-defined as demonstrated by the intense VE-cadherin staining. VE-
cadherin is a major component of EC-cell junctions and is the primary determinant of 
contact integrity. Its presence is critical in controlling vascular permeability to cells and 
other substances. Unlike other EC junction molecules (such as PECAM) cadherins are 
linked to the actin cytoskeleton through catenins thereby strengthening intercellular 
contacts. VE-cadherin also mediates cell proliferation through contact inhibition via 
various signaling processes87-88. This suggests that the formation of a confluent 
monolayer contributes to quiescence in ECs. The presence of intense VE-cadherin 
staining in the current 3D co-cultures is a positive sign suggesting that the HCAECs are 
in a healthy quiescent state with strong junctions that inhibit overgrowth of HCASMCs 
into the HCAEC layer and that the structure as a whole is representative of a native 
artery. This property is important for tissue engineered vascular substitutes since wide 
junctional gaps may result in dysfunction causing the tissue to behave as a pathological 
vessel66. The alignment of the underlying HCASMCs in Figure 4.10 is difficult to make 
out partly due to the high cell density and partly due to the varying directions in which 
different layers of HCASMCs are aligned. It seems as though some of the HCASMCs 
were organized perpendicular to the direction of the HCAECs as seen in vivo. 
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Realignment of HCAECs in co-culture has been observed by other investigators81 as a 
result of reorganization of the ECM between the two cell layers.   
A study by Lavender et al.65 examining the effects of culturing ECs on 
proliferating SMCs showed that ECs adhered with lower efficiency and attached as 
clusters over the underlying SMCs, failing to form a confluent monolayer. In addition, 
the EC population continuously declined and after 6 days in co-culture, only few cells 
were left. In comparison ECs seeded onto a confluent, quiescent layer of SMCs attached 
uniformly and formed a confluent layer that could be sustained for at least 10 days65. 
Chaterji et al.83 reported similar observations. It should be noted that in both 
investigations serum withdrawal was used to induce a quiescent, contractile phenotype in 
SMCs. Although the present study did not induce contractility in the HCASMCs prior to 
HCAEC seeding, varying HCASMC densities were used to examine their effects on EC 
attachment. In co-cultures employing sub-confluent HCASMC densities it was observed 
that although HCAECs preferentially adhered to the underlying HCASMCs, the 
attachment was non-uniform. Over longer culture durations this could result in HCAEC 
detachment as well as heterogeneous HCASMC phenotypes as reported in literature65. It 
is also likely that there would be overgrowth of one cell layer into the other resulting in 
the loss of a distinct layered structure. Therefore, in order to avoid this undesirable 
outcome, a seeding density of 750,000 – which resulted in multiple dense and confluent 
layers of HCASMCs - was chosen for subsequent experiments.  
Similar experiments were carried out to determine the effect of varying HCAEC 
seeding density on co-culture stability. A confluent endothelium has important 
implications for tissue engineered vascular substitutes. In vivo, the endothelial monolayer 
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regulates the transport of molecules into the vascular bed, prevents thrombosis, and 
regulates the growth and function of the underlying SMCs89-91. Loss of an intact 
endothelium can result in intimal hyperplasia – characterized by migration and 
proliferation of SMCs92. Similar pathologies have been observed in vascular grafts 
lacking an intact endothelium. This exemplifies the importance of an intact confluent 
endothelium in the maintenance of a differentiated SMC phenotype. Studies conducted 
by Chaterji et al.83 revealed that culturing of SMCs with a subconfluent layer of ECs 
induced a hyperplastic state and loss of differentiation markers after 48 hours. On the 
other hand, a confluent layer of ECs permitted co-culture stability for 40 days83. In the 
present work, HCAECs were seeded at densities of 200,000 cells/scaffold or 400,000 
cells/scaffold. Since cultures utilizing 200,000 ECs/scaffold were successful in achieving 
a confluent monolayer over the entire scaffold surface, the data for the experiment 
involving 400,000 cells/scaffold is not shown. With the exception of one notable 
difference (described below), the co-culture structure appeared identical irrespective of 
HCAEC seeding density and so a seeding density of 200,000 ECs/scaffold was used in 
subsequent experiments. Figure 4.11 shows images taken from co-cultures employing 
400,000 ECs/scaffold. Interestingly, there appeared to be tubular structures at the top 
surface of the scaffold. Though difficult to conclusively assert, some areas of these 
structures are composed of both HCASMCs and HCAECs and somewhat resemble an 
inverted artery wall with a very narrow lumen (indicated by arrows in Figure 4.11). A 
possible explanation for the rearrangement of cells into these structures is the 
overcrowding of cells resulting from an excess of HCAECs during seeding. By virtue of 
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the nature of ECs, and as a result of contact inhibition, the excess cells likely preferred 
arrangement into tubular structures rather than a second monolayer.    
 
Figure 4.11: Formation of tubular structures in HCASMCs co-cultured with excess 
HCAECs. Images taken at the seeding surface (0 µm) of scaffolds used for culturing 750,000 
HCASMCs and 400,000 HCAECs. HCASMCs are stained with CTG (green) while HCAEC-cell 
junctions are stained with VE-cadherin (red). All nuclei are labeled with Hoechst 33342 (blue). 
Arrow indicates the hollow lumen of the tubular structures. Scale bar, 20 µm. 
 
These cells appear to be arranged end-to-end as evidenced by the gaps between 
individual nuclei; this organization is typically seen in in vitro angiogenesis models93-95. 
Another structural feature that was observed in these cultures (and other monocultures 
and co-cultures) was the hill-and-valley growth pattern of HCASMCs. Because HCAECs 
(likely) attached to the in situ fibrillar FN molecules, they adhered to the underlying 
HCASMCs regardless of their topography and so the confluence of the HCAEC 
monolayer was unaffected. Hill-and-valley formation is characteristic of SMCs that have 
been monocultured and has been noted by several investigators96-98. In the cited studies, 
the hill-and-valley growth pattern was inhibited in co-culture by ECs. However, these 
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studies utilized a bi-layered co-culture configuration in which ECs and SMCs were 
cultured on opposite sides of a PET membrane and were cultured together for durations 
exceeding 48 hours. On the other hand, Powel et al.96 showed that whereas hill-and-
valley formation was arrested in co-cultures using a bi-layer format, the same was not 
observed in co-cultures using a monolayer format (ECs grown directly over SMCs). It is 
possible that extended co-culture durations in the present work would result in the 
rearrangement of cells into a more planar structure but the use of dynamic culturing 
would likely correct this problem prior to the initiation of co-culture99.  
The formation of multiple confluent SMC layers and a monolayer of ECs are 
critical in the replication of both the normal arterial structure and physiological functions. 
In vivo, ECs line the innermost surface of the artery wall, creating a barrier between the 
blood and the subendothelial tissue. This lining consists of a confluent cell monolayer 
that if disrupted can lead to a pathogenic response such as that seen in atherosclerosis. 
Therefore, in the current study, it was important to achieve confluent distinct layers of 
HCAECs and HCASMCs.  
 
4.3.5 Effect of Varying Matrigel Concentration on HCAEC Attachment 
 
Matrigel was incorporated into co-culture constructs in an attempt to mimic the 
basement membrane found in native blood vessels. In vivo, the ECs that line the lumen of 
the vessel are bound to a substrate of ECM molecules (collagen IV, heparin sulfate 
proteoglycans and the glycoproteins LN and nidogen/entactin) that comprise the 
basement membrane95. These proteins play a role in maintaining the stability of the 
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vessel, in regulating EC behavior and in sustaining the ECs in a well-differentiated 
state94.  In vitro studies have tested the effects of these proteins (alone or in combination) 
on EC attachment and differentiation. For instance, culturing of rat microvascular ECs on 
substrates of FN, collagen III or collagen I enhances proliferation while culturing on 
substrates of LN or collagen IV (basement membrane components) promote attachment 
and differentiation94. Matrigel has been extensively used to promote morphological 
differentiation of ECs93-94. Tubule formation in these and other studies95 has been 
attributed to the actions of LN. LN is the primary component of Matrigel followed by 
collagen IV, heparin sulfate proteoglycans, entactin and nidogen. Therefore, it was 
hypothesized that a low concentration of Matrigel would enhance HCAEC attachment 
and would maintain a (quiescent) differentiated state through activities mediated by LN.  
As per the manufacturer’s instructions, a highly diluted solution of Matrigel was applied 
to bare PCU scaffolds and also to co-cultures in order to avoid HCAEC capillary 
formation while still promoting cell attachment. The formation of capillaries in this co-
culture model would be disadvantageous in that it would firstly create a heterogeneous 
structure and may secondly result in heterogeneous signaling and cell behaviors- thereby 
hampering our ability to study the interactions between HCAECs and HCASMCs in 
direct contact in a controlled manner. Two different dilutions were investigated to 
determine the extent to which Matrigel promoted HCAEC attachment. HCAEC 
distribution on Matrigel-coated scaffolds and Matrigel-incorporated co-cultures are 
shown in the Figures 4.12 and 4.13 respectively.  
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Figure 4.12: Effect of Matrigel on HCAEC attachment to PCU. ECs cultured for 48 hours on 
PCU scaffolds containing no Matrigel (A,D), Matrigel at 1:50 dilution (B,E) and Matrigel at 
1:100 dilution (C,F) at 10x (A-C) and 40x (D-F) magnifications. Cell-cell junctions are stained 
with VE-cadherin (red) and nuclei are labeled with Hoechst 33342 (blue). Scale bars, 200µm (A-
C), and 20µm (D-F). 
 
Images of monocultures show that HCAECs readily adhered to the scaffold in all 
instances and no areas lacking cells could be seen. On Matrigel-coated scaffolds, cells 
appeared as though they were more densely packed together so the addition of Matrigel 
may have mildly promoted cell attachment. In addition, there were a greater number of 
cells exhibiting intensely stained VE-cadherin based junctions on scaffolds coated with 
Matrigel. This is not surprising since LN promotes a differentiated phenotype in which 
ECs form well-defined junctional complexes (a characteristic of native vascular ECs).  
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When comparing the images from monocultures (Figure 4.12) to images from co-
cultures (Figures 4.10 and 4.13) a difference in morphology, alignment and cadherin 
staining can be discerned. HCAECs cultured alone on scaffolds had a cobblestone shape 
where as HCAECs cultured over SMCs had an elongated shape. This finding is consistent 
with literature reports which have shown a shift in EC morphology from cobblestone in 
monoculture to elongated in co-cultures with differentiated SMCs65, 81, 83, 100. Whereas 
HCAECs showed no particular pattern of alignment in monocultures, co-cultured cells 
were relatively aligned in the direction of the underlying HCASMCs. As discussed 
earlier, this could be attributed to the organization of the fibrillar FN that is produced by 
HCASMCs.  Lastly, HCAECs in co-culture stained more intensely for VE-cadherin than 
HCAECs cultured alone. This observation is also consistent with reported findings where 
an increase in tight junction formation in co-cultures of ECs and SMCs were observed 
compared with monocultured ECs101. Although tight junctions are not the same as 
cadherins junctions, they are a measure of contact integrity.  
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Figure 4.13: Effect of Matrigel on HCAEC attachment in co-culture. HCAECs cultured for 
48 hours on HCASMC-scaffold constructs containing no Matrigel (A,D), Matrigel at 1:50 
dilution (B,E) and Matrigel at 1:100 dilution (C,F) at 10x (A-C) and 40x (D-F) magnifications. 
HCAEC-cell junctions are stained with VE-cadherin (red) while HCASMCs are stained with the 
cytoskeletal marker CTG (green). All nuclei are labeled with Hoechst 33342 (blue). Scale bars, 
200µm. 
 
Images of co-culture constructs employing a medial layer of Matrigel are shown 
in Figure 4.13. Since the effects of Matrigel were not drastic in HCAEC monocultures it 
was not expected that Matrigel addition in co-culture would have any profound effects. 
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Consistent with this, no differences could be seen among the three conditions with 
respect to HCAEC attachment and density. This may not be surprising since it has 
already been discussed that ECs prefer attachment to extracellular proteins from an in situ 
source (SMCs) rather than an exogenous source. Moreover, if the HCASMCs have 
already deposited enough fibrillar FN by the onset of co-culture to achieve full coverage 
of HCAECs then Matrigel’s presence should not have any added benefit (with respect to 
initial attachment). Matrigel (at a 1:100 dilution) was still incorporated in the experiments 
to follow since firstly, it did not produce any adverse effects, secondly, it may have had 
some benefit (such as creating a more extensive medial ECM) that could not be observed 
through gross examination, and finally, Matrigel may be required to maintain monolayer 
integrity over longer culture durations46. The latter point has been shown to be true in 
monocultures of ECs on PCU films so it may or may not be applicable to this scenario.  
 
4.3.6 Conditions Resulting in Successful Co-culture 
 
The conclusions of all above experiments are summarized in Table 1 below.  
Table 1: Summary of conditions required for successful co-culture  
Factor Preferred condition 
Fibronectin concentration 5 µg/scaffold 
Co-culture growth media composition 1 part EGM and 1 part SmGM 
HCASMC seeding density 750,000 cells/scaffold 
HCAEC seeding density 200,000 cells/scaffold 
Matrigel dilution 1:100 dilution in growth media 
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These are the culture conditions that resulted in the formation of a healthy and stable 3D 
co-culture construct. As mentioned previously, it was important to ascertain these optimal 
conditions in order to study the interactions between HCAECs and HCASMCs with 
relevance to the interactions in native states.  
 
4.4 Protein Expression Levels in HCASMCs and HCAECs 
from 3D Co-culture 
 
One of the main objectives of this study was to examine any phenotype changes 
that HCASMCs may undergo in the presence of HCAECs. Up until this point, results 
were largely qualitative observations made based on confocal images. HCASMCs 
cultured alone on PCU scaffolds had mixed morphologies with cells in the upper layers 
having an elongated, spindle-like shape characteristic of the contractile phenotype while 
cells deeper in the scaffold displayed a fibroblast-like morphology characteristic of the 
synthetic phenotype (Figure Appendix A3). The initiation of co-culture did not produce 
any noticeable changes in HCASMC morphology. Based on reports from literature, we 
had hypothesized a phenotypic shift from synthetic in monocultures to contractile in co-
cultures77,97,102. However, HCASMCs on the seeding surface of the scaffold already 
displayed a spindle-like morphology and so if the presence of ECs did activate a 
contractile phenotype shift, morphological changes would not be observed. However, the 
contractile morphology of the HCASMCs, may not necessarily correlate with the 
contractile phenotype, that is, the elongated HCASMCs may have been in a non-
proliferative state without a simultaneous expression of contractile marker proteins. For 
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instance, Grenier et al.47 noticed most HCASMCs cultured on PCU scaffolds to be 
elongated but cells expressing contractile marker proteins were found next to cells devoid 
of any contractile marker protein expression. Similarly Lin et al.21 observed a 
heterogeneous expression of contractile protein markers in elongated HCASMCs cultured 
on PCU scaffolds. Therefore, qualitative observations alone cannot be used to 
definitively ascertain the phenotype of the SMCs. For this reason it was necessary to 
examine the relative contractile protein expression levels to deduce if there was a 
differential regulation between HCASMCs in monoculture and HCASMCs in co-culture. 
 
4.4.1 Effect of Co-culture on Protein Expression Levels 
 
At the start of this study we hypothesized that HCASMC phenotype would be 
modulated from synthetic in monoculture to contractile in co-culture with HCAECs. This 
speculation was based on reports generated by other investigators77,97,102. For example, in 
a 2D direct co-culture system, Chaterji et al.83 described a dramatic increase in the 
expression of SM-α-actin by SMCs in co-culture compared to expression levels in 
monoculture and a less noticeable increase in calponin. Wallace et al.81 noticed a distinct 
upregulation of calponin in co-cultured SMC in a similar 2D direct co-culture system. 
However, there have not been any studies (that we are aware of) that have focused 
exclusively on the interactions between SMCs and ECs in a 3D environment in the 
absence of other stimuli (ie. mechanical or biochemical). Furthermore, the mechanisms 
regulating their interactions are not well understood. Therefore, in order to create a 
functional vascular substitute that closely mimics the native artery it is important to 
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understand the interactions between the individual cellular components of the substitute 
so that the tissue engineered vascular substitute can be optimized prior to implantation. 
 In preliminary screening experiments, the cell-scaffold constructs were directly 
lysed to extract proteins for Western blot analysis. However, this proved to be 
insufficient because protein lysates from both cell types were mixed in the co-culture 
condition, thus limiting our ability to determine which cell type was contributing to the 
expression levels. This led to the use of PECAM –conjugated magnetic beads for the 
separation of HCAECs from HCASMCs. PECAM is a cell surface molecule that is 
expressed by ECs, platelets and leukocytes (among others) and is not expressed by 
SMCs87. Cells were first detached using trypsin which has been shown to be effective in 
removing cells from PCU scaffolds21,47. The cell mixture was then incubated with 
PECAM- conjugated magnetic beads to facilitate binding of HCAECs to the beads. The 
beads were then separated from the remaining suspension (containing HCASMCs). 
Separation efficiency was tested to ensure cell extracts were not contaminated to any 
significant extent that it would limit Western blot analysis. Following SDS-PAGE, 
membranes were probed for the following proteins: SM-α-actin, calponin, Notch3, 
Jagged1 and GAPDH. SM-α-actin and calponin are SMC differentiation markers that are 
known to be upregulated in the contractile phenotype21-22 while Notch3 and Jagged1 are 
involved in a mechanism pathway that has been implicated in the regulation of SMC 
phenotype2-3,5-6,8-9,103. GAPDH is a housekeeping gene that is commonly used as an 
internal control. It is expressed at a relatively constant level regardless of experimental 
conditions and as such it provides a good method of normalizing quantitative gene/ 
protein expression data104. Normalized protein expression levels are shown with their 
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corresponding blots in Figure 4.14. Four culture conditions were compared: SMCs 
cultured alone (SM), SMCs co-cultured and subsequently separated (SM cc), ECs co-
cultured and subsequently separated (EC cc) and ECs cultured alone (EC).  
 
Figure 4.14: HCASMC and HCAEC protein expressions levels after 48 hours of co-culture 
on PCU scaffolds. Expression levels of Jagged1 (A), Notch 3 (B), SM α-actin (C) and Calponin 
(D) in HCASMCs and HCAECs cultured alone or together. Asterisks indicate statistically 
significant data (p<0.05). Nomencalture: EC (HCAECs from monoculture), EC cc (HCAECs in 
co-culture with HCASMCs and separated), SMC cc (HCASMCs in co-culture HCAECs and 
separated) and SM (HCASMCs from monoculture). 
 
When comparing HCASMCs cultured alone to HCASMCs from co-culture it is 
clear that co-culture induced a significant upregulation in contractile proteins (p<0.05). 
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Surprisingly, even basal levels of contractile proteins could not be detected in HCASMCs 
cultured alone. SM-α-actin and calponin are known to be present in the early to mid 
stages of VSMC differentiation25,105-106. This suggests that even after 4 days of HCASMC 
monoculture cells either did not begin a transition to the contractile phenotype or that 
very small populations of cells were expressing contractile markers in monoculture but 
these proteins were not at a high enough concentration to allow detection. Previous work 
involving the culture of HCASMCs on PCU scaffolds described some expression of 
contractile protein markers21,47. However, these studies involved longer culture durations 
or much larger samples from which proteins were collected. The absence of SM-α-actin 
and calponin from HCAECs in co-culture indicates that the separation protocol used was 
highly efficient.  
As part of the hypothesis that was earlier stated, we also speculated that the any 
observed modulations in HCASMC phenotype may in part be due to the actions of 
Notch3 and Jagged1. The Notch family of membrane-bound receptors has been shown to 
play a critical role in vascular development and remodeling. These receptors are part of a 
short-range signaling pathway that involves membrane-bound receptors and ligands that 
are expressed on adjacent cells5. Four Notch receptors (Notch1 to 4) and their ligands 
(Delta-like 1 and 2 and Jagged1 and 2) are expressed in ECs and SMCs in differing 
combinations2. Notch 3 is the predominant receptor that is expressed in VSMCs while 
Jagged1 is prominently expressed by vascular ECs and has also been detected in arterial 
SMCs1-4. Their crucial roles are exemplified in diseases such as Alagille syndrome and 
CADASIL which are consequences of mutations in Jagged1 and Notch33. Binding of the 
Notch receptor with its ligand (Jagged1) results in proteolytic cleavage of the receptor’s 
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intracellular domain which then translocates to the nucleus. This signal transduction 
pathway involves several effectors and ultimately prompts differentiation in VSMCs5. A 
host of in vivo and in vitro studies have demonstrated a vital function of Jagged1 in 
regulating SMC differentiation2,5-9. These studies formed the basis for our examination of 
expression levels of Notch3 and Jagged1 in HCAEC and HCASMCs.  
As shown in Figure 4.14, expression of both Notch3 and Jagged1 were 
upregulated in co-culture, indicated by the blots and the corresponding bar graph. As 
expected, Jagged1 was predominantly expressed by HCAECs and to a lesser but 
detectable degree by HCASMCs.  Unexpectedly, there was also no basal expression of 
Notch 3 or Jagged1 in monocultures. In the case of Jagged1, the differential expression 
was not as dramatic as in the other proteins. This is evidenced by the intensity of the 
bands on the Western blots as well as the scales used in the graphs. The absence of 
Jagged1 and Notch3 in monocultures was not in agreement with findings reported in 
literature. For instance, in a study by Ying et al.25 Jagged1 and in particular Notch 3 were 
noticeably expressed in HCAECs and HCASMCs respectively. Similarly Liu et al.2 
noticed a robust basal expression of Notch3 and Jagged1 in HCASMCs. In both cases, 
the expression of Notch3 in monocultured SMCs was accompanied by detectable 
amounts of SM-α-actin and calponin. In spite of these differences, the general trend in the 
current study was similar to that seen in the aforementioned work; co-culture augmented 
the expression of all four target proteins: Jagged1, Notch3, SM-α-actin and calponin. 
 
4.4.2 Effect of siRNA Knockdown of Jagged1 on Protein Expression 
Levels 
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At this point, no correlations between the target proteins could be inferred from 
the data. Therefore, the next logical step was to abrogate a component of the Notch 
signaling pathway and observe the downstream effects on differentiation markers. To this 
end, we knocked down the expression of Jagged1 in HCAECs using siRNA. It has 
previously been shown that EC derived Jagged1 and a model that enables heterotypic 
cell-cell contact are both requisites for enhancing Notch3 expression and subsequent 
contractile protein expressions25. One day prior to the initiation of co-culture, HACECs 
were transfected with either Jagged1 siRNA or control siRNA. 20 hours later, HCAECs 
were seeded over HCASMCs and cultured for 48 hours as per the co-culture protocol 
described in Chapter 3. Transfection efficiency was tested to ensure sufficient 
knockdown of Jagged1 in HCAECs.  
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Figure 4.15: Effect of siRNA knockdown of Jagged1 on protein expression levels in co-
culture. Expression levels of Jagged1 (A), Notch3 (B), SM α-actin (C) and calponin (D) in 
HCASMCs and HCAECs cultured alone or together. Asterisks indicate statistically significant 
data (p<0.05). Nomenclature: EC siD (control siRNA-transfected HCAECs in monoculture), EC 
siJAG (Jagged1 siRNA-transfected HCAECs in monoculture), EC cc siD (control siRNA-
transfected HCAECs in co-culture with SMCs and separated), SM cc siD (HCASMCs co-
cultured with EC siD and separated), EC cc siJAG (Jagged1 siRNA-transfected HCAECs in co-
culture with SMCs and separated) and  SM cc siJAG (HCASMCs co-cultured with EC siJAG and 
separated) 
 
As shown in the Figure 4.15 Jagged1 in siRNA transfected HCAECs was not 
detected in neither monoculture nor co-culture indicating successful knockdown of 
Jagged1. As expected, the result of culturing HCASMCs with Jagged1 siRNA 
transfected- HCAECs was a significant (approximately three-fold) downregulation of 
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Notch3 in HCASMCs. Interestingly, although the reduction in SM-α-actin expression 
was significant it was not as marked. This was surprising since Notch has been shown to 
directly target SM-α-actin expression23.In comparison the reduction in calponin 
expression was more than two-fold. Nonetheless, it is possible that because Notch3 
expression was not entirely diminished in co-culture with Jagged1 siRNA-transfected 
HCAECs, a low level of Notch activation was sufficient in propagating its own 
expression and that of α-actin. Using a series of Notch pathway inhibitors and activators, 
Liu et al. showed that Notch3 receptor activation is essential in promoting further Notch3 
expression. They suggested that initial Notch3 activation by Jagged1-presenting ECs 
initiates an autoregulatory positive feedback loop in SMCs whereby the SMCs increase 
expression of Notch3 and Jagged1, thus maintaining themselves in a differentiated state2. 
Hence, the sustained expression of Notch3 and SM-α-actin in the present experiment may 
be a result of initial Notch3 activation by a few Jagged1-expressing HCAECs and 
subsequent amplification of this signal by homotypic cell-cell interactions between 
HCASMCs that are expressing Notch3 and neighboring HCASMCs that are expressing 
Jagged1. It may be of interest to examine if the expression of these proteins is time-
dependant. Perhaps the expression of both Notch3 and SM-α-actin are considerably 
abrogated within the first few hours of co-culture but are recovered overtime. 
Furthermore, because SM-α-actin expression precedes that of calponin during the process 
of SMC differentiation, calponin expression may be recovered more slowly. 
Alternatively, it is possible that other regulatory mechanisms were in place that 
counteracted the downregulation of SM-α-actin. For instance, the protein kinase A and 
phosphoinositide 3-kinase/Akt pathways have also been implicated in EC-induced 
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VSMC differentiation. Fetalvero et al.107 reported an increase in SM-α-actin, calponin, 
MHY and h-caldesmon expression in VSMCs cultured with iloprost. They showed that 
iloprost activated the VSMC-expressed prostacylin receptor and in turn activated the 
protein kinase A pathway. Iloprost is an analog of prostacyclin which is an EC-derived 
molecule that is important in the maintenance of a differentiated VSMC phenotype in 
vivo107. In a bilayered EC-SMC co-culture model, Brown et al.108 demonstrated that 
bovine aortic ECs augmented the expression of differentiation markers in bovine aortic 
SMCs through activation of the phosphoinositide 3-kinase/Akt signaling pathway in 
SMCs. Therefore, these signaling pathways are likely activated simultaneously by EC-
expressed factors so disruption of one pathway may not result in complete suppression of 
VSMC differentiation markers. This is especially true if the signal strength of one of 
these pathways is far greater than the signal strength of another’s. A comparative study to 
determine the extent to which each of these pathways plays a role in HCASMC 
differentiation may be helpful in revealing the optimal method through which the 
phenotype of these can be modulated. Although it has been shown, in the present study 
and in others, that direct co-culture of VECs and VSMCs is a requirement for Notch 
signaling, the same may not be true for Akt activation108 or prostacylin receptor 
activation107. Incorporation of multiple factors into PCU scaffolds and into the co-culture 
model described in this study could conceptually have a synergistic effect on HCASMCs 
differentiation.  
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Chapter 5 – Conclusions and Future 
Directions 
	
5.1 Conclusions 
 
The present study involved the examination HCASMCs phenotype modulation in 
the presence of HCAECs. Initial exploratory experiments that involved the assessment of 
gene expression in HCAECs and HCASMCs in 2D cultures indicated that the contractile 
phenotype can be induced via the Notch3 signaling pathway only when HCASMCs are 
directly cultured with HCAECs. Soluble Jagged1 protein and Jagged1-immobilized 
Dynabeads failed to upregulate SM-α-actin and calponin gene expression levels; 
however, siRNA knockdown of Jagged1 in HCAECs demonstrated a direct link between 
HCAEC-expressed Jagged1 and contractile gene expression in HCASMCs. This led to 
the investigation of direct co-culture of HCAECs and HCASMCs on 3D PCU scaffolds. 
In order to create a cell-scaffold construct that mimics the in vivo artery structure a series 
of experiments were carried out to optimize the culture conditions. It was determined that 
a FN concentration of 5 µg/cm2 resulted in increased HCASMCs attachment and that a 
growth media composition of 1 part SmGM and 1 part EGM enabled the maintenance of 
high HCASMC and HCAEC densities. Long-term HCASMC cultures on PCU scaffolds 
showed that cells were able to proliferate and maintain a healthy morphology which 
illustrated the value of using PCU scaffolds as a support structure for engineered vascular 
substitutes. Short-term cultures were then carried out using high HCASMC densities. A 
seeding density of 750,000 HCASMCs/ scaffold resulted in the formation of a dense, 
confluent HCASMCs layer which facilitated the formation of a confluent layer of 
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HCAECs. Matrigel was then incorporated into the co-culture model to mimic the 
basement membrane matrix that is found underlying the endothelium of native blood 
vessels. The addition of Matrigel did not produce a significant difference, with respect to 
HCAEC attachment, however, a dilution of 1:100 (Matrigel: growth media) was still 
employed in subsequent cultures. To conclusively affirm the phenotype of HCASMCs in 
co-culture with HCAECs, Western blot was performed and protein expression levels 
were analyzed. It was demonstrated that co-culture of HCASMCs with HCAECs 
upregulated the expression of the contractile proteins SM-α-actin and calponin as well as 
Notch3 and Jagged1. Gene knockdown of Jagged1 in HCAECs using siRNA established 
a direct link between the Notch3 signaling pathway and HCASMC phenotype. A 
reduction in Jagged1 expression by HCAECs in co-culture resulted in decreased 
expression of SM-α-actin and calponin by HCASMCs in co-culture.  
These results demonstrate that co-cultures of HCAECs and HCASMCs can be 
successfully sustained on PCU scaffolds and that HCAECs modulate HCASMC 
phenotype in 3D cultures via the Notch3 signaling pathway. These findings are highly 
relevant in the context of vascular tissue engineering. The success of a tissue engineered 
vascular substitute is highly dependent on the phenotype of the VSMCs that reside within 
it. Based on these findings the Notch3 signaling pathway can potentially be exploited for 
regulating the phenotype of VSMCs during in vitro tissue maturation. This could be 
achieved through augmenting the expression of one or more of the components involved 
in the Notch3 signaling pathway.  
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5.2 Future Directions 
 
Follow-up studies should be performed to determine the long term effect of 
HCAEC on HCASMC phenotype. It would be undesirable for HCASMCs to revert back 
to a synthetic phenotype so it should be verified that HCAECs are capable of maintaining 
HCASCMs in a contractile phenotype for periods greater than 48 hours. Furthermore, it 
would be beneficial to perform a comparative study to examine the relative effects of 
different phenotype regulatory molecules and mechanisms. These include illoprost and 
TGF-β1 which have both been shown to induce the contractile phenotype in VSMCs1-3.  
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Appendix – Supplementary Data 
 
Figure A1: Cell infiltration in long-term cultures of HCASMCs on PCU scaffolds. Images of 
HCASMCs cultured on PCU scaffolds for 8 (A, C, E) and 16 (B, D, F, G, H) days at depths of 0 
µm (A, B), 40 µm (C, D), 140 µm (E, F), 180 µm (G) and 200 µm (H) from the seeding surface. 
F-actin is stained with Alexa Fluor®488 Phalloidin (green) and nuclei are stained with Hoechst 
33342 (blue). Scale bar, 100 µm. 
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Figure A2: HCASMCs cultured for 72 hours on PCU scaffolds coated with varying amounts 
of FN. HCASMCs cultured on PCU scaffolds coated with 0 (A), 5 (B) and 10 (C) µg of 
FN/scaffold. Cells are live-stained with a the cytoskeletal marker CTG (green) and Hoechst 
33342 (blue) for the nuclei Scale bar, 200 µm 
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Figure A3: Serial optical sections of HCASMCs cultured for 72 hours on PCU scaffolds at a 
density of 750,000 cells/scaffold. Selected images from a single image stack are shown at depths 
of 0 µm (A), 10 µm (B), 20 µm (C), 30 µm (D), 40 µm (E), 50 µm (F), 60 µm (G), 70 µm (H), 80 
µm (I)from the seeding surface. Cells are live-stained with a the cytoskeletal marker CTG (green) 
and Hoechst 33342 (blue) for the nuclei Scale bar, 20 µm. 
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Figure A4: 48-hour co-cultures of HCAECs with sub-confluent HCASMCs on PCU 
scaffolds. HCAECs can be seen forming clusters (A), intermixing with the HCASMC layer (B) 
and adhering to the scaffold struts (C). PCU scaffold is shown as mild green fluorescence in panel 
C. HCASMCs are stained with CTG (green) while HCAEC-cell junctions are stained with VE-
cadherin (red). All nuclei are labeled with Hoechst 33342 (blue). Scale bar, 20 µm.  
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